MAP1LC3B Human (+)-Tetrandrine increases expression EXP 6480464 tetrandrine results in increased expression of MAP1LC3B CTD PMID:26822499 MAP1LC3B Human (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 MAP1LC3B Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAP1LC3B mRNA CTD PMID:22079256 MAP1LC3B Human (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of MAP1LC3B protein CTD PMID:32512070 MAP1LC3B Human (1->4)-beta-D-glucan multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP1LC3B mRNA CTD PMID:36331819 MAP1LC3B Human 1,2-dimethylhydrazine decreases expression ISO Map1lc3b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MAP1LC3B mRNA CTD PMID:22206623 MAP1LC3B Human 1,2-dimethylhydrazine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3B mRNA CTD PMID:22206623 MAP1LC3B Human 1,3-dichloropropan-2-ol decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 1 and 3-dichloro-2-propanol results in decreased expression of MAP1LC3B protein CTD PMID:36000575 MAP1LC3B Human 1-monopalmitoylglycerol multiple interactions EXP 6480464 Chloroquine promotes the reaction [palmitoyl glycerol results in increased lipidation of MAP1LC3B protein] CTD PMID:37466199 MAP1LC3B Human 1-monopalmitoylglycerol increases lipidation EXP 6480464 palmitoyl glycerol results in increased lipidation of MAP1LC3B protein CTD PMID:37466199 MAP1LC3B Human 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of MAP1LC3B mRNA and 1-nitropyrene results in increased expression of MAP1LC3B protein CTD PMID:29078374 MAP1LC3B Human 1-nitropyrene increases expression ISO Map1lc3b (Mus musculus) 6480464 1-nitropyrene results in increased expression of MAP1LC3B mRNA and 1-nitropyrene results in increased expression of MAP1LC3B protein CTD PMID:29078374 MAP1LC3B Human 1-nitropyrene multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 protein affects the reaction [1-nitropyrene results in increased expression of MAP1LC3B protein] CTD PMID:29078374 MAP1LC3B Human 17alpha-ethynylestradiol affects expression ISO Map1lc3b (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of MAP1LC3B mRNA CTD PMID:17555576 MAP1LC3B Human 17alpha-ethynylestradiol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MAP1LC3B mRNA CTD PMID:17942748 MAP1LC3B Human 17alpha-ethynylestradiol decreases expression ISO Map1lc3b (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of MAP1LC3B mRNA CTD PMID:17942748 MAP1LC3B Human 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone multiple interactions EXP 6480464 2' more ... CTD PMID:38521250 MAP1LC3B Human 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [2 more ... CTD PMID:29518472 MAP1LC3B Human 2,2',5,5'-tetrachlorobiphenyl increases cleavage ISO Map1lc3b (Rattus norvegicus) 6480464 2 more ... CTD PMID:29518472 MAP1LC3B Human 2,2',5,5'-tetrachlorobiphenyl increases cleavage EXP 6480464 2 more ... CTD PMID:29518472 MAP1LC3B Human 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [2 more ... CTD PMID:29518472 MAP1LC3B Human 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene affects expression ISO Map1lc3b (Mus musculus) 6480464 2 more ... CTD PMID:32721735 MAP1LC3B Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP1LC3B mRNA CTD PMID:16054898 more ... MAP1LC3B Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP1LC3B mRNA CTD PMID:33387578 MAP1LC3B Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map1lc3b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3B mRNA CTD PMID:21570461 MAP1LC3B Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map1lc3b (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3B mRNA CTD PMID:22298810 MAP1LC3B Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Map1lc3b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP1LC3B mRNA CTD PMID:19770486 MAP1LC3B Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MAP1LC3B mRNA CTD PMID:17942748 MAP1LC3B Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein] CTD PMID:30503585 MAP1LC3B Human 2,4,6-trinitrobenzenesulfonic acid increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein CTD PMID:30503585 MAP1LC3B Human 2,4-D multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 lycium barbarum polysaccharide inhibits the reaction [2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA] CTD PMID:34464015 MAP1LC3B Human 2,4-D decreases expression ISO Map1lc3b (Mus musculus) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA CTD PMID:35099110 MAP1LC3B Human 2,4-D affects localization ISO Map1lc3b (Mus musculus) 6480464 2 and 4-Dichlorophenoxyacetic Acid affects the localization of MAP1LC3B protein CTD PMID:35099110 MAP1LC3B Human 2,4-D multiple interactions ISO Map1lc3b (Mus musculus) 6480464 lycium barbarum polysaccharide inhibits the reaction [2 more ... CTD PMID:35099110 MAP1LC3B Human 2,4-D decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA CTD PMID:34464015 MAP1LC3B Human 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one multiple interactions EXP 6480464 buprofezin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:36287832 MAP1LC3B Human 2-amino-14,16-dimethyloctadecan-3-ol increases expression EXP 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in increased expression of MAP1LC3B protein modified form CTD PMID:32044396 MAP1LC3B Human 2-deoxy-D-glucose multiple interactions EXP 6480464 ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] more ... CTD PMID:20593179 MAP1LC3B Human 2-deoxy-D-glucose increases prenylation EXP 6480464 Deoxyglucose results in increased prenylation of MAP1LC3B protein CTD PMID:20593179 MAP1LC3B Human 2-hydroxyethyl methacrylate multiple interactions EXP 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA] and 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein] CTD PMID:28184909 MAP1LC3B Human 2-hydroxyethyl methacrylate increases expression EXP 6480464 hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA and hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein CTD PMID:28184909 MAP1LC3B Human 25-hydroxycholesterol increases lipidation EXP 6480464 25-hydroxycholesterol results in increased lipidation of MAP1LC3B protein CTD PMID:39197811 MAP1LC3B Human 3,3',5-triiodo-L-thyronine increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Triiodothyronine results in increased lipidation of MAP1LC3B protein CTD PMID:30209975 MAP1LC3B Human 3,3',5-triiodo-L-thyronine increases expression ISO Map1lc3b (Mus musculus) 6480464 Triiodothyronine results in increased expression of MAP1LC3B mRNA CTD PMID:30209975 MAP1LC3B Human 3,3',5-triiodo-L-thyronine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bafilomycin A1 promotes the reaction [Triiodothyronine results in increased lipidation of MAP1LC3B protein] and Triiodothyronine promotes the reaction [bafilomycin A1 results in increased lipidation of MAP1LC3B protein] CTD PMID:30209975 MAP1LC3B Human 3,4-methylenedioxymethamphetamine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP1LC3B mRNA CTD PMID:30071829 MAP1LC3B Human 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions EXP 6480464 MK-886 inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] CTD PMID:30677399 MAP1LC3B Human 3-chloropropane-1,2-diol multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35149085 MAP1LC3B Human 3-chloropropane-1,2-diol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 alpha-Chlorohydrin results in increased lipidation of and results in increased localization of MAP1LC3B protein and ginsenoside Rb1 promotes the reaction [alpha-Chlorohydrin results in increased lipidation of and results in increased localization of MAP1LC3B protein] CTD PMID:38373586 MAP1LC3B Human 3-chloropropane-1,2-diol multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:35149085 and PMID:38373586 MAP1LC3B Human 3-chloropropane-1,2-diol increases lipidation EXP 6480464 alpha-Chlorohydrin results in increased lipidation of MAP1LC3B protein CTD PMID:35149085 MAP1LC3B Human 3-methyladenine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of MAP1LC3B protein] more ... CTD PMID:21325019 more ... MAP1LC3B Human 3-methyladenine increases lipidation EXP 6480464 3-methyladenine results in increased lipidation of MAP1LC3B protein CTD PMID:34281243 MAP1LC3B Human 3-methyladenine increases expression EXP 6480464 3-methyladenine results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 MAP1LC3B Human 3-methyladenine decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine results in decreased expression of MAP1LC3B mRNA CTD PMID:30611790 MAP1LC3B Human 3-methyladenine decreases cleavage ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine results in decreased cleavage of MAP1LC3B protein CTD PMID:26804720 MAP1LC3B Human 3-methyladenine affects metabolic processing EXP 6480464 3-methyladenine affects the metabolism of MAP1LC3B protein CTD PMID:23680031 MAP1LC3B Human 3-methyladenine multiple interactions EXP 6480464 3-methyladenine affects the reaction [Alpha-Amanitin affects the lipidation of MAP1LC3B protein] more ... CTD PMID:20962572 more ... MAP1LC3B Human 3-methyladenine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [2 more ... CTD PMID:18640276 more ... MAP1LC3B Human 3-methyladenine decreases expression ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine results in decreased expression of MAP1LC3B mRNA and 3-methyladenine results in decreased expression of MAP1LC3B protein modified form CTD PMID:21681844 and PMID:32512069 MAP1LC3B Human 3-Nitrofluoranthene increases expression ISO Map1lc3b (Mus musculus) 6480464 3-nitrofluoranthene results in increased expression of MAP1LC3B protein CTD PMID:19041363 MAP1LC3B Human 3-nitropropanoic acid multiple interactions EXP 6480464 3-nitropropionic acid inhibits the reaction [Curcumin results in increased localization of MAP1LC3B protein] CTD PMID:37634662 MAP1LC3B Human 3H-1,2-dithiole-3-thione decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of MAP1LC3B mRNA CTD PMID:19162173 MAP1LC3B Human 4,4'-diaminodiphenylmethane decreases expression ISO Map1lc3b (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of MAP1LC3B mRNA CTD PMID:18648102 MAP1LC3B Human 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions EXP 6480464 4 more ... CTD PMID:37156403 MAP1LC3B Human 4-hydroxynon-2-enal increases expression ISO Map1lc3b (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of MAP1LC3B mRNA CTD PMID:19191707 MAP1LC3B Human 4-hydroxyphenyl retinamide increases expression ISO Map1lc3b (Mus musculus) 6480464 Fenretinide results in increased expression of MAP1LC3B mRNA CTD PMID:28973697 MAP1LC3B Human 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of MAP1LC3B mRNA CTD PMID:16671099 MAP1LC3B Human 4-methoxy-TEMPO increases metabolic processing EXP 6480464 4-methoxy-2 more ... CTD PMID:28993908 MAP1LC3B Human 4-phenylbutyric acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of and results in increased localization of MAP1LC3B protein] and 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 and PMID:38065397 MAP1LC3B Human 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of MAP1LC3B protein] more ... CTD PMID:30025493 more ... MAP1LC3B Human 4-phenylbutyric acid decreases expression EXP 6480464 4-phenylbutyric acid results in decreased expression of MAP1LC3B protein CTD PMID:36640941 MAP1LC3B Human 4-phenylbutyric acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] and 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased lipidation of MAP1LC3B protein] CTD PMID:26804720 and PMID:37654027 MAP1LC3B Human 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [Rotenone results in increased lipidation of and results in increased cleavage of MAP1LC3B protein] and Decitabine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] CTD PMID:19577553 and PMID:30673822 MAP1LC3B Human 5-fluorouracil affects response to substance EXP 6480464 MAP1LC3B protein affects the susceptibility to Fluorouracil CTD PMID:15548681 MAP1LC3B Human 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:24145604 MAP1LC3B Human 6-propyl-2-thiouracil decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 MAP1LC3B Human 7-ketocholesterol increases expression ISO Map1lc3b (Mus musculus) 6480464 7-ketocholesterol results in increased expression of MAP1LC3B protein CTD PMID:24445604 MAP1LC3B Human 7-ketocholesterol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 CD38 gene mutant form promotes the reaction [7-ketocholesterol results in increased expression of MAP1LC3B protein] CTD PMID:24445604 MAP1LC3B Human abamectin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA] CTD PMID:34748272 MAP1LC3B Human abamectin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 abamectin results in increased expression of MAP1LC3B mRNA CTD PMID:34748272 MAP1LC3B Human ABT-737 multiple interactions EXP 6480464 MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP3 protein] more ... CTD PMID:20104024 MAP1LC3B Human acadesine multiple interactions EXP 6480464 acadesine promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein] CTD PMID:33002460 MAP1LC3B Human acetaldehyde increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Acetaldehyde results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 MAP1LC3B Human acetaldehyde multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Cyanamide promotes the reaction [Acetaldehyde results in increased lipidation of MAP1LC3B protein] CTD PMID:24492484 MAP1LC3B Human acetamide decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 acetamide results in decreased expression of MAP1LC3B mRNA CTD PMID:31881176 MAP1LC3B Human acrolein increases lipidation EXP 6480464 Acrolein results in increased lipidation of MAP1LC3B protein CTD PMID:34238121 MAP1LC3B Human acrolein multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Acrolein results in increased lipidation of MAP1LC3B protein] and ATG7 protein affects the reaction [Acrolein results in increased lipidation of MAP1LC3B protein] CTD PMID:34238121 MAP1LC3B Human acrylamide decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of MAP1LC3B mRNA CTD PMID:28959563 MAP1LC3B Human acrylamide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acrylamide results in increased expression of and results in increased lipidation of MAP1LC3B protein and TFEB protein inhibits the reaction [Acrylamide results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:37172712 MAP1LC3B Human acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAP1LC3B mRNA CTD PMID:32763439 MAP1LC3B Human actinomycin D multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Dactinomycin inhibits the reaction [Ethanol results in increased expression of MAP1LC3B protein] CTD PMID:24095927 MAP1LC3B Human Aescin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG5 protein affects the reaction [Escin promotes the reaction [Dietary Fats results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:36905866 MAP1LC3B Human Aescin increases lipidation EXP 6480464 Escin results in increased lipidation of MAP1LC3B protein CTD PMID:36905866 MAP1LC3B Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MAP1LC3B mRNA CTD PMID:27153756 MAP1LC3B Human aflatoxin B1 increases expression ISO Map1lc3b (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of MAP1LC3B mRNA and Aflatoxin B1 results in increased expression of MAP1LC3B protein CTD PMID:35304092 and PMID:35810998 MAP1LC3B Human aflatoxin B1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 PRKN protein affects the reaction [Aflatoxin B1 results in increased expression of MAP1LC3B mRNA] CTD PMID:35304092 MAP1LC3B Human aldehydo-D-glucose multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 more ... MAP1LC3B Human aldehydo-D-glucose increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in increased expression of MAP1LC3B mRNA CTD PMID:38444079 MAP1LC3B Human aldehydo-D-glucose decreases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in decreased lipidation of MAP1LC3B protein CTD PMID:35243728 MAP1LC3B Human aldehydo-D-glucose increases expression EXP 6480464 Glucose deficiency results in increased expression of MAP1LC3B protein and Glucose deficiency results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 MAP1LC3B Human aldehydo-D-glucose multiple interactions EXP 6480464 U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form] CTD PMID:34580807 MAP1LC3B Human aldehydo-D-glucose decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in decreased expression of MAP1LC3B protein CTD PMID:29128638 MAP1LC3B Human aldrin decreases expression ISO Map1lc3b (Mus musculus) 6480464 Aldrin results in decreased expression of MAP1LC3B mRNA CTD PMID:18579281 MAP1LC3B Human alginic acid increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Alginic Acid results in increased lipidation of MAP1LC3B protein CTD PMID:35066102 MAP1LC3B Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MAP1LC3B mRNA CTD PMID:29743969 and PMID:33167477 MAP1LC3B Human all-trans-retinoic acid multiple interactions EXP 6480464 ATG5 protein affects the reaction [Tretinoin results in increased metabolism of and affects the localization of MAP1LC3B protein] more ... CTD PMID:28978663 and PMID:29743969 MAP1LC3B Human allethrin increases lipidation EXP 6480464 Allethrins results in increased lipidation of MAP1LC3B protein CTD PMID:36528879 MAP1LC3B Human aloxistatin multiple interactions EXP 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:27635674 more ... MAP1LC3B Human aloxistatin increases lipidation EXP 6480464 aloxistatin results in increased lipidation of MAP1LC3B protein CTD PMID:33124469 MAP1LC3B Human aloxistatin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:26483381 and PMID:27635674 MAP1LC3B Human alpha,alpha-trehalose increases expression ISO Map1lc3b (Mus musculus) 6480464 Trehalose results in increased expression of MAP1LC3B mRNA CTD PMID:30335591 MAP1LC3B Human alpha,alpha-trehalose increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Trehalose results in increased expression of MAP1LC3B protein CTD PMID:38579922 MAP1LC3B Human alpha,alpha-trehalose increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Trehalose results in increased cleavage of MAP1LC3B protein CTD PMID:29486218 MAP1LC3B Human alpha,alpha-trehalose multiple interactions ISO Map1lc3b (Mus musculus) 6480464 TFEB affects the reaction [Trehalose results in increased expression of MAP1LC3B mRNA] CTD PMID:30335591 MAP1LC3B Human alpha-amanitin affects lipidation EXP 6480464 Alpha-Amanitin affects the lipidation of MAP1LC3B protein CTD PMID:37329965 MAP1LC3B Human alpha-amanitin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Alpha-Amanitin results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:37329965 MAP1LC3B Human alpha-amanitin multiple interactions EXP 6480464 3-methyladenine affects the reaction [Alpha-Amanitin affects the lipidation of MAP1LC3B protein] and Alpha-Amanitin inhibits the reaction [dorsomorphin results in decreased lipidation of MAP1LC3B protein] CTD PMID:37329965 MAP1LC3B Human Alpinetin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:31676321 MAP1LC3B Human Alpinetin multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [TNF protein results in increased expression of and results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:31676321 MAP1LC3B Human aluminium atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:34547296 MAP1LC3B Human aluminium(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:34547296 MAP1LC3B Human amiodarone multiple interactions EXP 6480464 Amiodarone results in increased expression of and results in increased lipidation of MAP1LC3B protein and Amiodarone results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:25881747 and PMID:37661063 MAP1LC3B Human amiodarone increases lipidation EXP 6480464 Amiodarone results in increased lipidation of MAP1LC3B protein CTD PMID:32651653 MAP1LC3B Human amitrole decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Amitrole results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 MAP1LC3B Human ammonium chloride affects expression ISO Map1lc3b (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of MAP1LC3B mRNA CTD PMID:16483693 MAP1LC3B Human ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of MAP1LC3B protein CTD PMID:35504338 MAP1LC3B Human ammonium chloride increases lipidation EXP 6480464 Ammonium Chloride results in increased lipidation of MAP1LC3B protein CTD PMID:31927068 MAP1LC3B Human ammonium chloride increases expression ISO Map1lc3b (Mus musculus) 6480464 Ammonium Chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:31310755 MAP1LC3B Human ammonium chloride increases metabolic processing EXP 6480464 Ammonium Chloride results in increased metabolism of MAP1LC3B protein CTD PMID:29908302 MAP1LC3B Human ammonium chloride multiple interactions EXP 6480464 bafilomycin A1 affects the reaction [Ammonium Chloride results in increased metabolism of MAP1LC3B protein] and NR1I2 protein affects the reaction [Ammonium Chloride results in increased metabolism of MAP1LC3B protein] CTD PMID:29908302 MAP1LC3B Human amphotericin B increases expression ISO Map1lc3b (Mus musculus) 6480464 Amphotericin B results in increased expression of MAP1LC3B protein CTD PMID:23988732 MAP1LC3B Human amsacrine increases expression EXP 6480464 Amsacrine results in increased expression of MAP1LC3B protein CTD PMID:37451322 MAP1LC3B Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein] and pyrazolanthrone promotes the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:34861471 and PMID:35130734 MAP1LC3B Human antimycin A increases expression EXP 6480464 Antimycin A results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 MAP1LC3B Human apigenin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] and Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] CTD PMID:29247770 MAP1LC3B Human apigenin increases expression EXP 6480464 Apigenin results in increased expression of MAP1LC3B protein modified form CTD PMID:29247770 MAP1LC3B Human apocynin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 acetovanillone analog inhibits the reaction [Chlorpyrifos results in increased lipidation of MAP1LC3B protein] CTD PMID:29859868 MAP1LC3B Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of MAP1LC3B mRNA CTD PMID:33212167 MAP1LC3B Human arsane increases expression EXP 6480464 Arsenic results in increased expression of MAP1LC3B protein and Arsenic results in increased expression of MAP1LC3B protein modified form CTD PMID:27413109 and PMID:29248574 MAP1LC3B Human arsane multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP1LC3B mRNA CTD PMID:31844926 MAP1LC3B Human arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29248574 and PMID:32525701 MAP1LC3B Human arsane increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic results in increased expression of MAP1LC3B protein CTD PMID:27413109 MAP1LC3B Human arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of MAP1LC3B protein and Arsenic results in increased expression of MAP1LC3B protein modified form CTD PMID:27413109 and PMID:29248574 MAP1LC3B Human arsenic atom multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP1LC3B mRNA CTD PMID:31844926 MAP1LC3B Human arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29248574 and PMID:32525701 MAP1LC3B Human arsenic atom increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic results in increased expression of MAP1LC3B protein CTD PMID:27413109 MAP1LC3B Human arsenite(3-) increases lipidation EXP 6480464 arsenite results in increased lipidation of MAP1LC3B protein CTD PMID:34929507 MAP1LC3B Human arsenite(3-) multiple interactions EXP 6480464 arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:33097607 and PMID:34929507 MAP1LC3B Human arsenous acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA and Arsenic Trioxide results in increased expression of MAP1LC3B protein CTD PMID:30032600 more ... MAP1LC3B Human arsenous acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 MAP1LC3B Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA more ... CTD PMID:29307831 more ... MAP1LC3B Human arsenous acid increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 MAP1LC3B Human arsenous acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29111283 and PMID:35195477 MAP1LC3B Human arsenous acid multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] more ... CTD PMID:28978663 more ... MAP1LC3B Human arsenous acid increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 MAP1LC3B Human arsenous acid increases cleavage EXP 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 MAP1LC3B Human arsenous acid increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 MAP1LC3B Human artesunate multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:33002460 MAP1LC3B Human artesunate increases lipidation EXP 6480464 Artesunate results in increased lipidation of MAP1LC3B protein CTD PMID:33002460 MAP1LC3B Human asperuloside multiple interactions ISO Map1lc3b (Mus musculus) 6480464 asperuloside promotes the reaction [Cyclophosphamide results in increased lipidation of MAP1LC3B protein] and dorsomorphin inhibits the reaction [asperuloside promotes the reaction [Cyclophosphamide results in increased lipidation of MAP1LC3B protein]] CTD PMID:38348709 MAP1LC3B Human atazanavir sulfate increases expression EXP 6480464 Atazanavir Sulfate results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 MAP1LC3B Human atazanavir sulfate multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 MAP1LC3B Human atorvastatin calcium multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein] CTD PMID:34939712 MAP1LC3B Human atrazine increases expression ISO Map1lc3b (Mus musculus) 6480464 Atrazine results in increased expression of MAP1LC3B protein CTD PMID:25259610 and PMID:33485040 MAP1LC3B Human atrazine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Atrazine results in increased expression of MAP1LC3B protein] CTD PMID:25259610 MAP1LC3B Human auramine O multiple interactions EXP 6480464 ALDH1A1 protein promotes the reaction [Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein] and Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein CTD PMID:28722353 MAP1LC3B Human AZD4547 multiple interactions EXP 6480464 bafilomycin A1 affects the reaction [AZD4547 affects the expression of MAP1LC3B protein modified form] CTD PMID:26853465 MAP1LC3B Human AZD4547 affects expression EXP 6480464 AZD4547 affects the expression of MAP1LC3B protein modified form CTD PMID:26853465 MAP1LC3B Human bafilomycin A1 increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 bafilomycin A1 results in increased lipidation of MAP1LC3B protein CTD PMID:32525084 MAP1LC3B Human bafilomycin A1 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Doxorubicin co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein more ... CTD PMID:32278738 more ... MAP1LC3B Human bafilomycin A1 increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 bafilomycin A1 results in increased expression of MAP1LC3B protein modified form CTD PMID:32278738 MAP1LC3B Human bafilomycin A1 increases lipidation EXP 6480464 bafilomycin A1 results in increased lipidation of MAP1LC3B protein CTD PMID:33124469 more ... MAP1LC3B Human bafilomycin A1 increases expression ISO Map1lc3b (Mus musculus) 6480464 bafilomycin A1 results in increased expression of MAP1LC3B protein modified form CTD PMID:31310755 MAP1LC3B Human bafilomycin A1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:30209975 more ... MAP1LC3B Human bafilomycin A1 increases lipidation ISO Map1lc3b (Mus musculus) 6480464 bafilomycin A1 results in increased lipidation of MAP1LC3B protein CTD PMID:30209975 MAP1LC3B Human bafilomycin A1 increases cleavage EXP 6480464 bafilomycin A1 results in increased cleavage of MAP1LC3B protein CTD PMID:29248574 MAP1LC3B Human bafilomycin A1 decreases degradation ISO Map1lc3b (Rattus norvegicus) 6480464 bafilomycin A1 results in decreased degradation of MAP1LC3B protein modified form CTD PMID:26459185 MAP1LC3B Human bafilomycin A1 multiple interactions EXP 6480464 [bafilomycin A1 co-treated with Miconazole] results in increased expression of MAP1LC3B protein more ... CTD PMID:23880069 more ... MAP1LC3B Human bafilomycin A1 increases expression EXP 6480464 bafilomycin A1 results in increased expression of MAP1LC3B protein more ... CTD PMID:24145604 more ... MAP1LC3B Human Bafilomycin B1 increases expression ISO Map1lc3b (Mus musculus) 6480464 bafilomycin B1 results in increased expression of MAP1LC3B protein modified form CTD PMID:32738330 MAP1LC3B Human Bafilomycin B1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bafilomycin B1 promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form] and Cisplatin promotes the reaction [bafilomycin B1 results in increased expression of MAP1LC3B protein modified form] CTD PMID:32738330 MAP1LC3B Human Bafilomycin B1 multiple interactions EXP 6480464 [Rotenone co-treated with bafilomycin B1] results in increased lipidation of and results in increased cleavage of MAP1LC3B protein CTD PMID:30673822 MAP1LC3B Human BAPTA multiple interactions ISO Map1lc3b (Mus musculus) 6480464 1 more ... CTD PMID:37981210 MAP1LC3B Human belinostat increases expression EXP 6480464 belinostat results in increased expression of MAP1LC3B mRNA CTD PMID:19606018 MAP1LC3B Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAP1LC3B mRNA CTD PMID:22316170 MAP1LC3B Human benzo[a]pyrene increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Benzo(a)pyrene results in increased lipidation of MAP1LC3B protein CTD PMID:32619457 MAP1LC3B Human benzo[a]pyrene multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with Resveratrol] promotes the reaction [MAP1LC3B protein binds to TOMM20 protein] more ... CTD PMID:32619457 MAP1LC3B Human benzo[a]pyrene increases expression ISO Map1lc3b (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAP1LC3B mRNA CTD PMID:22228805 MAP1LC3B Human benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 MAP1LC3B Human berberine multiple interactions EXP 6480464 [Berberine co-treated with Cisplatin] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:36070022 MAP1LC3B Human berberine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Berberine inhibits the reaction [Chlorpyrifos results in decreased expression of MAP1LC3B mRNA] CTD PMID:35439518 MAP1LC3B Human berberine increases localization ISO Map1lc3b (Rattus norvegicus) 6480464 Berberine results in increased localization of MAP1LC3B protein CTD PMID:35439518 MAP1LC3B Human beta-ionone multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [beta-ionone results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:36843289 MAP1LC3B Human beta-lapachone multiple interactions EXP 6480464 beta-lapachone affects the localization of and results in increased metabolism of MAP1LC3B protein CTD PMID:21035436 MAP1LC3B Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of MAP1LC3B mRNA and beta-lapachone results in increased expression of MAP1LC3B protein CTD PMID:38218311 MAP1LC3B Human betulinic acid increases expression EXP 6480464 Betulinic Acid results in increased expression of MAP1LC3B protein modified form CTD PMID:30136359 MAP1LC3B Human betulinic acid multiple interactions EXP 6480464 Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:30136359 MAP1LC3B Human bifenthrin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bifenthrin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:38040083 MAP1LC3B Human bis(2-ethylhexyl) phthalate increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of MAP1LC3B mRNA and Diethylhexyl Phthalate results in increased expression of MAP1LC3B protein CTD PMID:29606031 and PMID:38522500 MAP1LC3B Human bis(2-ethylhexyl) phthalate increases localization ISO Map1lc3b (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased localization of MAP1LC3B protein CTD PMID:36583613 MAP1LC3B Human bis(2-ethylhexyl) phthalate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased localization of MAP1LC3B protein] CTD PMID:36583613 MAP1LC3B Human bisphenol A affects expression ISO Map1lc3b (Rattus norvegicus) 6480464 bisphenol A affects the expression of MAP1LC3B mRNA CTD PMID:25181051 MAP1LC3B Human bisphenol A affects splicing ISO Map1lc3b (Mus musculus) 6480464 bisphenol A affects the splicing of MAP1LC3B mRNA CTD PMID:37894381 MAP1LC3B Human bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of MAP1LC3B protein CTD PMID:38006930 MAP1LC3B Human bisphenol A increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 bisphenol A results in increased lipidation of MAP1LC3B protein CTD PMID:31551937 MAP1LC3B Human bisphenol A multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [bisphenol A results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:34281243 and PMID:38326183 MAP1LC3B Human bisphenol A increases lipidation ISO Map1lc3b (Mus musculus) 6480464 bisphenol A results in increased lipidation of MAP1LC3B protein CTD PMID:38326183 MAP1LC3B Human bisphenol A increases lipidation EXP 6480464 bisphenol A results in increased lipidation of MAP1LC3B protein CTD PMID:38326183 MAP1LC3B Human bisphenol A affects localization ISO Map1lc3b (Rattus norvegicus) 6480464 bisphenol A affects the localization of MAP1LC3B protein CTD PMID:38006930 MAP1LC3B Human bisphenol A increases expression ISO Map1lc3b (Mus musculus) 6480464 bisphenol A results in increased expression of MAP1LC3B protein CTD PMID:38725370 MAP1LC3B Human bisphenol A multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bisphenol A results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:34281243 and PMID:38725370 MAP1LC3B Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP1LC3B protein CTD PMID:29275510 MAP1LC3B Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP1LC3B mRNA CTD PMID:30903817 MAP1LC3B Human bisphenol A increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 bisphenol A results in increased expression of MAP1LC3B protein modified form CTD PMID:27539358 MAP1LC3B Human bisphenol A increases methylation ISO Map1lc3b (Mus musculus) 6480464 bisphenol A results in increased methylation of MAP1LC3B promoter CTD PMID:27312807 MAP1LC3B Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of MAP1LC3B protein CTD PMID:34186270 MAP1LC3B Human bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of MAP1LC3B protein CTD PMID:34186270 MAP1LC3B Human bleomycin A2 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Soot inhibits the reaction [Bleomycin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31302203 MAP1LC3B Human bleomycin A2 increases expression ISO Map1lc3b (Mus musculus) 6480464 Bleomycin results in increased expression of MAP1LC3B protein modified form CTD PMID:31302203 MAP1LC3B Human bortezomib multiple interactions EXP 6480464 MAP1LC3B protein affects the reaction [Bortezomib results in increased phosphorylation of NFKBIA protein] CTD PMID:24085292 MAP1LC3B Human brefeldin A multiple interactions EXP 6480464 [aloxistatin co-treated with pepstatin] promotes the reaction [Brefeldin A results in increased expression of and results in increased lipidation of MAP1LC3B protein] and Brefeldin A results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32397857 MAP1LC3B Human buprofezin multiple interactions EXP 6480464 buprofezin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:36287832 MAP1LC3B Human buspirone increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Buspirone results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human busulfan increases expression ISO Map1lc3b (Mus musculus) 6480464 Busulfan results in increased expression of MAP1LC3B protein CTD PMID:38220133 MAP1LC3B Human busulfan multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Busulfan results in increased expression of MAP1LC3B protein] CTD PMID:38220133 MAP1LC3B Human butachlor increases expression ISO Map1lc3b (Mus musculus) 6480464 butachlor results in increased expression of MAP1LC3B protein CTD PMID:34351278 MAP1LC3B Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of MAP1LC3B mRNA CTD PMID:26079696 MAP1LC3B Human butein increases lipidation EXP 6480464 butein results in increased lipidation of MAP1LC3B protein CTD PMID:35130734 MAP1LC3B Human butein multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35130734 MAP1LC3B Human C60 fullerene increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of MAP1LC3B mRNA CTD PMID:19167457 MAP1LC3B Human cadmium atom increases expression ISO Map1lc3b (Mus musculus) 6480464 Cadmium results in increased expression of MAP1LC3B mRNA and Cadmium results in increased expression of MAP1LC3B protein modified form CTD PMID:19126599 more ... MAP1LC3B Human cadmium atom multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP1LC3B protein more ... CTD PMID:27872163 and PMID:32347499 MAP1LC3B Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased metabolism of MAP1LC3B protein more ... CTD PMID:31319114 MAP1LC3B Human cadmium atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-(2 more ... CTD PMID:27492225 more ... MAP1LC3B Human cadmium atom affects localization ISO Map1lc3b (Mus musculus) 6480464 Cadmium affects the localization of MAP1LC3B protein CTD PMID:29111403 MAP1LC3B Human cadmium dichloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-(2 more ... CTD PMID:21325019 more ... MAP1LC3B Human cadmium dichloride multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP1LC3B protein CTD PMID:27872163 MAP1LC3B Human cadmium dichloride multiple interactions EXP 6480464 2-aminoethoxydiphenyl borate inhibits the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:25639782 more ... MAP1LC3B Human cadmium dichloride increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Cadmium Chloride results in increased cleavage of MAP1LC3B protein CTD PMID:29486218 MAP1LC3B Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MAP1LC3B mRNA more ... CTD PMID:25639782 more ... MAP1LC3B Human cadmium dichloride increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form CTD PMID:21325019 MAP1LC3B Human cadmium dichloride increases expression ISO Map1lc3b (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MAP1LC3B protein and Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form CTD PMID:21325019 and PMID:35843418 MAP1LC3B Human caffeine increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Caffeine results in increased cleavage of MAP1LC3B protein CTD PMID:30555576 MAP1LC3B Human caffeine increases cleavage EXP 6480464 Caffeine results in increased cleavage of MAP1LC3B protein CTD PMID:30555576 MAP1LC3B Human caffeine multiple interactions EXP 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Caffeine results in increased cleavage of MAP1LC3B protein] more ... CTD PMID:30555576 MAP1LC3B Human caffeine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-(2 more ... CTD PMID:30555576 MAP1LC3B Human calcidiol multiple interactions EXP 6480464 Calcifediol inhibits the reaction [TNF protein promotes the reaction [BNIP3 protein binds to MAP1LC3B protein]] and Calcifediol inhibits the reaction [TNF protein results in increased expression of MAP1LC3B protein] CTD PMID:34255241 MAP1LC3B Human calcitriol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Calcitriol promotes the reaction [bisphenol A results in increased expression of MAP1LC3B protein] CTD PMID:38725370 MAP1LC3B Human calix[6]arene increases expression EXP 6480464 calix(6)arene results in increased expression of MAP1LC3B protein modified form CTD PMID:23872419 MAP1LC3B Human Calpeptin multiple interactions EXP 6480464 calpeptin inhibits the reaction [dehydroeburicoic acid affects the localization of MAP1LC3B protein] and calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] CTD PMID:19848398 MAP1LC3B Human capivasertib increases expression EXP 6480464 capivasertib results in increased expression of MAP1LC3B protein modified form CTD PMID:26853465 MAP1LC3B Human capivasertib multiple interactions EXP 6480464 bafilomycin A1 promotes the reaction [capivasertib results in increased expression of MAP1LC3B protein modified form] CTD PMID:26853465 MAP1LC3B Human carbamazepine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of MAP1LC3B mRNA CTD PMID:35786680 MAP1LC3B Human carbon disulfide decreases expression ISO Map1lc3b (Mus musculus) 6480464 Carbon Disulfide results in decreased expression of MAP1LC3B mRNA and Carbon Disulfide results in decreased expression of MAP1LC3B protein CTD PMID:31369747 MAP1LC3B Human carbon disulfide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B mRNA] and N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B protein] CTD PMID:31369747 MAP1LC3B Human carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of MAP1LC3B protein CTD PMID:24389112 MAP1LC3B Human carbon nanotube increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Nanotubes more ... CTD PMID:32951350 MAP1LC3B Human carbon nanotube increases expression ISO Map1lc3b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:24929217 and PMID:25620056 MAP1LC3B Human carbon nanotube decreases expression ISO Map1lc3b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 MAP1LC3B Human carglumic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B mRNA] and N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B protein] CTD PMID:31369747 MAP1LC3B Human carteolol affects localization EXP 6480464 Carteolol affects the localization of MAP1LC3B protein CTD PMID:37120125 MAP1LC3B Human celecoxib multiple interactions EXP 6480464 MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP3 protein] more ... CTD PMID:20104024 MAP1LC3B Human cerium trichloride increases expression EXP 6480464 cerous chloride results in increased expression of MAP1LC3B protein CTD PMID:38253231 MAP1LC3B Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP1LC3B gene] CTD PMID:28238834 MAP1LC3B Human CGS-21680 multiple interactions EXP 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Caffeine results in increased cleavage of MAP1LC3B protein] CTD PMID:30555576 MAP1LC3B Human chenodeoxycholic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Chenodeoxycholic Acid results in increased expression of MAP1LC3B protein CTD PMID:24189133 MAP1LC3B Human chenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 MAP1LC3B Human chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of MAP1LC3B mRNA CTD PMID:26352163 MAP1LC3B Human chloroquine increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Chloroquine results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 and PMID:30301768 MAP1LC3B Human chloroquine affects localization ISO Map1lc3b (Mus musculus) 6480464 Chloroquine affects the localization of MAP1LC3B protein CTD PMID:30208301 MAP1LC3B Human chloroquine increases lipidation EXP 6480464 Chloroquine results in increased lipidation of MAP1LC3B protein CTD PMID:23880069 more ... MAP1LC3B Human chloroquine increases expression ISO Map1lc3b (Mus musculus) 6480464 Chloroquine results in increased expression of MAP1LC3B protein and Chloroquine results in increased expression of MAP1LC3B protein modified form CTD PMID:25884947 and PMID:31310755 MAP1LC3B Human chloroquine increases cleavage EXP 6480464 Chloroquine results in increased cleavage of MAP1LC3B protein CTD PMID:29248574 MAP1LC3B Human chloroquine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]] more ... CTD PMID:29476062 more ... MAP1LC3B Human chloroquine decreases degradation ISO Map1lc3b (Mus musculus) 6480464 Chloroquine results in decreased degradation of MAP1LC3B protein modified form CTD PMID:32861759 MAP1LC3B Human chloroquine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Ethanol co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:24492484 more ... MAP1LC3B Human chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of MAP1LC3B mRNA more ... CTD PMID:24095927 more ... MAP1LC3B Human chloroquine multiple interactions EXP 6480464 [4-nitrochalcone co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:23880069 more ... MAP1LC3B Human chloroquine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine results in increased expression of MAP1LC3B mRNA more ... CTD PMID:17643062 more ... MAP1LC3B Human chlorpyrifos increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Chlorpyrifos results in increased lipidation of MAP1LC3B protein CTD PMID:29859868 MAP1LC3B Human chlorpyrifos decreases localization ISO Map1lc3b (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased localization of MAP1LC3B protein CTD PMID:35439518 MAP1LC3B Human chlorpyrifos decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased expression of MAP1LC3B mRNA CTD PMID:35439518 MAP1LC3B Human chlorpyrifos increases expression ISO Map1lc3b (Mus musculus) 6480464 Chlorpyrifos results in increased expression of MAP1LC3B mRNA CTD PMID:37019170 MAP1LC3B Human chlorpyrifos multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 acetovanillone analog inhibits the reaction [Chlorpyrifos results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:29859868 and PMID:35439518 MAP1LC3B Human cholesterol increases expression EXP 6480464 Cholesterol results in increased expression of MAP1LC3B protein modified form CTD PMID:28275691 MAP1LC3B Human cholesterol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Cholesterol inhibits the reaction [Cadmium Chloride results in increased cleavage of MAP1LC3B protein] CTD PMID:29486218 MAP1LC3B Human cholic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Cholic Acid results in increased expression of MAP1LC3B protein CTD PMID:24189133 MAP1LC3B Human chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of MAP1LC3B mRNA CTD PMID:30690063 MAP1LC3B Human chromium(6+) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [chromium hexavalent ion affects the expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:36739042 MAP1LC3B Human chrysin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein] and chrysin inhibits the reaction [Colistin results in increased expression of MAP1LC3B protein] CTD PMID:28682524 and PMID:30273961 MAP1LC3B Human ciguatoxin CTX1B affects expression ISO Map1lc3b (Mus musculus) 6480464 Ciguatoxins affects the expression of MAP1LC3B mRNA CTD PMID:18353800 MAP1LC3B Human cisplatin multiple interactions EXP 6480464 [Berberine co-treated with Cisplatin] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:21191146 more ... MAP1LC3B Human cisplatin increases lipidation EXP 6480464 Cisplatin results in increased lipidation of MAP1LC3B protein CTD PMID:36070022 MAP1LC3B Human cisplatin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form] and Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MAP1LC3B protein modified form] CTD PMID:29476062 and PMID:32777238 MAP1LC3B Human cisplatin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 gene mutant form inhibits the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:29476062 more ... MAP1LC3B Human cisplatin increases expression ISO Map1lc3b (Mus musculus) 6480464 Cisplatin results in increased expression of MAP1LC3B protein and Cisplatin results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 more ... MAP1LC3B Human cisplatin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Cisplatin results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 MAP1LC3B Human cisplatin decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Cisplatin results in decreased expression of MAP1LC3B protein modified form CTD PMID:32777238 MAP1LC3B Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MAP1LC3B mRNA more ... CTD PMID:19561079 more ... MAP1LC3B Human Citreoviridin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] and Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 MAP1LC3B Human Citreoviridin increases expression ISO Map1lc3b (Mus musculus) 6480464 citreoviridin results in increased expression of MAP1LC3B protein modified form CTD PMID:31419397 MAP1LC3B Human Citreoviridin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 citreoviridin results in increased expression of MAP1LC3B protein modified form CTD PMID:31419397 MAP1LC3B Human Citreoviridin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Rosiglitazone inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:31419397 MAP1LC3B Human clobetasol increases expression ISO Map1lc3b (Mus musculus) 6480464 Clobetasol results in increased expression of MAP1LC3B mRNA CTD PMID:27462272 MAP1LC3B Human clofibrate decreases expression ISO Map1lc3b (Mus musculus) 6480464 Clofibrate results in decreased expression of MAP1LC3B mRNA CTD PMID:17585979 MAP1LC3B Human clofibrate increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Clofibrate results in increased expression of MAP1LC3B mRNA CTD PMID:21318169 MAP1LC3B Human clozapine multiple interactions EXP 6480464 [Chloroquine co-treated with Clozapine] results in increased lipidation of MAP1LC3B protein CTD PMID:36482696 MAP1LC3B Human clozapine increases lipidation EXP 6480464 Clozapine results in increased lipidation of MAP1LC3B protein CTD PMID:36482696 MAP1LC3B Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of MAP1LC3B mRNA CTD PMID:19320972 and PMID:19376846 MAP1LC3B Human colistin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 chrysin inhibits the reaction [Colistin results in increased expression of MAP1LC3B protein] more ... CTD PMID:30273961 and PMID:30318960 MAP1LC3B Human colistin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Colistin results in increased expression of MAP1LC3B mRNA and Colistin results in increased expression of MAP1LC3B protein CTD PMID:30273961 and PMID:30318960 MAP1LC3B Human copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA more ... CTD PMID:20971185 more ... MAP1LC3B Human copper atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:15467011 and PMID:31491480 MAP1LC3B Human copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA more ... CTD PMID:20971185 more ... MAP1LC3B Human copper(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:15467011 and PMID:31491480 MAP1LC3B Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of MAP1LC3B mRNA CTD PMID:17211630 MAP1LC3B Human copper(II) chloride increases lipidation ISO Map1lc3b (Mus musculus) 6480464 cupric chloride results in increased lipidation of MAP1LC3B protein CTD PMID:37981210 MAP1LC3B Human copper(II) chloride increases expression ISO Map1lc3b (Mus musculus) 6480464 cupric chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:32512069 MAP1LC3B Human copper(II) chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 1 more ... CTD PMID:32512069 and PMID:37981210 MAP1LC3B Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of MAP1LC3B mRNA CTD PMID:19549813 MAP1LC3B Human copper(II) sulfate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3B protein CTD PMID:31491480 MAP1LC3B Human cordycepin affects expression EXP 6480464 cordycepin affects the expression of MAP1LC3B mRNA CTD PMID:36881089 MAP1LC3B Human cordycepin multiple interactions EXP 6480464 Chloroquine inhibits the reaction [cordycepin results in increased expression of MAP1LC3B mRNA] CTD PMID:36299321 MAP1LC3B Human coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of MAP1LC3B mRNA CTD PMID:19167446 MAP1LC3B Human crocidolite asbestos decreases expression ISO Map1lc3b (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of MAP1LC3B mRNA CTD PMID:29279043 MAP1LC3B Human crocin-1 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Quercetin co-treated with crocin] inhibits the reaction [Blood Glucose results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:33021114 MAP1LC3B Human Cryptotanshinone multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein] more ... CTD PMID:28600121 MAP1LC3B Human Cryptotanshinone increases expression EXP 6480464 cryptotanshinone results in increased expression of MAP1LC3B protein CTD PMID:28600121 MAP1LC3B Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of MAP1LC3B protein CTD PMID:36640941 MAP1LC3B Human curcumin decreases expression ISO Map1lc3b (Mus musculus) 6480464 Curcumin results in decreased expression of MAP1LC3B protein CTD PMID:36640941 MAP1LC3B Human curcumin increases lipidation EXP 6480464 Curcumin results in increased lipidation of MAP1LC3B protein CTD PMID:34634291 MAP1LC3B Human curcumin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Curcumin results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:34634291 more ... MAP1LC3B Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of MAP1LC3B mRNA CTD PMID:34634291 MAP1LC3B Human curcumin increases localization EXP 6480464 Curcumin results in increased localization of MAP1LC3B protein CTD PMID:37634662 MAP1LC3B Human Curcumol multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 curcumol inhibits the reaction [VEGFA protein results in increased expression of MAP1LC3B mRNA] CTD PMID:33549628 MAP1LC3B Human cyanamide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Cyanamide promotes the reaction [Acetaldehyde results in increased lipidation of MAP1LC3B protein] CTD PMID:24492484 MAP1LC3B Human cyanamide increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Cyanamide results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 MAP1LC3B Human cyclophosphamide increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Cyclophosphamide results in increased lipidation of MAP1LC3B protein CTD PMID:38348709 MAP1LC3B Human cyclophosphamide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 asperuloside promotes the reaction [Cyclophosphamide results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:38348709 MAP1LC3B Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of MAP1LC3B mRNA CTD PMID:20106945 more ... MAP1LC3B Human cyclosporin A multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Cyclosporine inhibits the reaction [ginsenoside Rb1 promotes the reaction [alpha-Chlorohydrin results in increased lipidation of and results in increased localization of MAP1LC3B protein]] CTD PMID:38373586 MAP1LC3B Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 MAP1LC3B Human cypermethrin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 cypermethrin results in increased expression of MAP1LC3B mRNA CTD PMID:35876585 MAP1LC3B Human cypermethrin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 cypermethrin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:38040083 MAP1LC3B Human D-glucose multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 more ... MAP1LC3B Human D-glucose increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in increased expression of MAP1LC3B mRNA CTD PMID:38444079 MAP1LC3B Human D-glucose decreases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in decreased lipidation of MAP1LC3B protein CTD PMID:35243728 MAP1LC3B Human D-glucose increases expression EXP 6480464 Glucose deficiency results in increased expression of MAP1LC3B protein and Glucose deficiency results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 MAP1LC3B Human D-glucose multiple interactions EXP 6480464 U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form] CTD PMID:34580807 MAP1LC3B Human D-glucose decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in decreased expression of MAP1LC3B protein CTD PMID:29128638 MAP1LC3B Human D-mannopyranose multiple interactions EXP 6480464 Mannose inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] CTD PMID:20593179 MAP1LC3B Human dapagliflozin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein] and dapagliflozin inhibits the reaction [Streptozocin results in decreased expression of MAP1LC3B mRNA] CTD PMID:34939712 and PMID:37352119 MAP1LC3B Human DDE decreases expression ISO Map1lc3b (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of MAP1LC3B mRNA CTD PMID:32721735 MAP1LC3B Human DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of MAP1LC3B mRNA CTD PMID:38568856 MAP1LC3B Human deguelin increases expression EXP 6480464 deguelin results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 MAP1LC3B Human Dehydroeburicoic acid affects localization EXP 6480464 dehydroeburicoic acid affects the localization of MAP1LC3B protein CTD PMID:19848398 MAP1LC3B Human Dehydroeburicoic acid multiple interactions EXP 6480464 calpeptin inhibits the reaction [dehydroeburicoic acid affects the localization of MAP1LC3B protein] more ... CTD PMID:19848398 MAP1LC3B Human deoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 MAP1LC3B Human deoxynivalenol increases expression ISO Map1lc3b (Mus musculus) 6480464 deoxynivalenol results in increased expression of MAP1LC3B mRNA CTD PMID:35381244 MAP1LC3B Human deoxynivalenol decreases expression ISO Map1lc3b (Mus musculus) 6480464 deoxynivalenol results in decreased expression of MAP1LC3B protein CTD PMID:38040082 MAP1LC3B Human deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of MAP1LC3B mRNA CTD PMID:34677630 MAP1LC3B Human deoxynivalenol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3B mRNA]] more ... CTD PMID:35381244 and PMID:38040082 MAP1LC3B Human desferrioxamine B increases expression EXP 6480464 Deferoxamine results in increased expression of MAP1LC3B protein CTD PMID:25301941 MAP1LC3B Human desferrioxamine B multiple interactions EXP 6480464 Deferoxamine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of and results in increased lipidation of MAP1LC3B protein] and Iron affects the reaction [Deferoxamine results in increased expression of MAP1LC3B protein] CTD PMID:25301941 and PMID:32687844 MAP1LC3B Human dexamethasone increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of MAP1LC3B mRNA CTD PMID:20032058 MAP1LC3B Human dexamethasone multiple interactions EXP 6480464 MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA] and MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] CTD PMID:23111315 MAP1LC3B Human dexamethasone multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1LC3B mRNA] CTD PMID:20032058 MAP1LC3B Human dexmedetomidine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Dexmedetomidine affects the reaction [MIR330 protein affects the lipidation of MAP1LC3B protein] and Dexmedetomidine inhibits the reaction [Sevoflurane results in decreased lipidation of MAP1LC3B protein] CTD PMID:34590382 MAP1LC3B Human dextran sulfate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:31676321 MAP1LC3B Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA more ... CTD PMID:29307831 more ... MAP1LC3B Human diarsenic trioxide increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 MAP1LC3B Human diarsenic trioxide multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29111283 and PMID:35195477 MAP1LC3B Human diarsenic trioxide increases cleavage EXP 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 MAP1LC3B Human diarsenic trioxide increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 MAP1LC3B Human diarsenic trioxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 MAP1LC3B Human diarsenic trioxide multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] more ... CTD PMID:28978663 more ... MAP1LC3B Human diarsenic trioxide increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA and Arsenic Trioxide results in increased expression of MAP1LC3B protein CTD PMID:30032600 more ... MAP1LC3B Human diarsenic trioxide increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 MAP1LC3B Human dibenzofuran affects localization EXP 6480464 dibenzofuran affects the localization of MAP1LC3B protein CTD PMID:22173198 MAP1LC3B Human dibenzofuran increases expression EXP 6480464 dibenzofuran results in increased expression of MAP1LC3B protein modified form CTD PMID:22173198 MAP1LC3B Human Dibromoacetonitrile multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine inhibits the reaction [dibromoacetonitrile results in increased expression of and results in increased localization of MAP1LC3B protein] more ... CTD PMID:38065397 MAP1LC3B Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of MAP1LC3B mRNA CTD PMID:37042841 MAP1LC3B Human dibutyl phthalate increases expression ISO Map1lc3b (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of MAP1LC3B mRNA CTD PMID:21266533 MAP1LC3B Human dibutyl phthalate increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of MAP1LC3B protein CTD PMID:30053495 MAP1LC3B Human dibutyl phthalate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] and 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 MAP1LC3B Human dibutyl phthalate multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] and 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 MAP1LC3B Human dibutyl phthalate increases cleavage ISO Map1lc3b (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein CTD PMID:26804720 MAP1LC3B Human dibutyl phthalate increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein CTD PMID:26804720 MAP1LC3B Human dideuterium oxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Deuterium Oxide results in increased expression of and results in increased lipidation of MAP1LC3B protein] and Deuterium Oxide results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:37751786 MAP1LC3B Human diethyl malate increases expression EXP 6480464 diethyl malate results in increased expression of MAP1LC3B mRNA CTD PMID:38498338 MAP1LC3B Human diisononyl phthalate increases expression ISO Map1lc3b (Mus musculus) 6480464 diisononyl phthalate results in increased expression of MAP1LC3B protein CTD PMID:37976928 MAP1LC3B Human diisononyl phthalate multiple interactions EXP 6480464 ATF4 protein promotes the reaction [diisononyl phthalate results in increased expression of MAP1LC3B protein] and DDIT4 protein promotes the reaction [diisononyl phthalate results in increased expression of MAP1LC3B protein] CTD PMID:37976928 MAP1LC3B Human diisononyl phthalate increases expression EXP 6480464 diisononyl phthalate results in increased expression of MAP1LC3B protein CTD PMID:37976928 MAP1LC3B Human diosgenin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35149085 MAP1LC3B Human diosgenin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein and alpha-Chlorohydrin inhibits the reaction [Diosgenin results in decreased lipidation of MAP1LC3B protein] CTD PMID:35149085 MAP1LC3B Human diosgenin decreases lipidation EXP 6480464 Diosgenin results in decreased lipidation of MAP1LC3B protein CTD PMID:35149085 MAP1LC3B Human diosgenin decreases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Diosgenin results in decreased lipidation of MAP1LC3B protein CTD PMID:35149085 MAP1LC3B Human dioxygen multiple interactions EXP 6480464 [Chloroquine co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:20593179 and PMID:33203845 MAP1LC3B Human dioxygen multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein more ... CTD PMID:35307376 MAP1LC3B Human dioxygen increases expression ISO Map1lc3b (Mus musculus) 6480464 Oxygen deficiency results in increased expression of MAP1LC3B mRNA CTD PMID:23624791 MAP1LC3B Human diquat multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Diquat co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA CTD PMID:27057282 MAP1LC3B Human diquat increases expression EXP 6480464 Diquat results in increased expression of MAP1LC3B protein CTD PMID:38128689 MAP1LC3B Human diquat multiple interactions EXP 6480464 Diquat results in increased lipidation of and results in increased localization of MAP1LC3B protein more ... CTD PMID:38128689 MAP1LC3B Human disodium selenite multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 MAP1LC3B Human disodium selenite multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 MAP1LC3B Human disodium selenite multiple interactions EXP 6480464 [Sodium Selenite co-treated with (1 more ... CTD PMID:28757135 MAP1LC3B Human disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA CTD PMID:24690739 MAP1LC3B Human disulfiram increases expression EXP 6480464 Disulfiram results in increased expression of MAP1LC3B mRNA CTD PMID:34182011 MAP1LC3B Human dorsomorphin increases lipidation EXP 6480464 dorsomorphin results in increased lipidation of MAP1LC3B protein CTD PMID:31900833 MAP1LC3B Human dorsomorphin decreases lipidation EXP 6480464 dorsomorphin results in decreased lipidation of MAP1LC3B protein CTD PMID:37329965 MAP1LC3B Human dorsomorphin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 dorsomorphin inhibits the reaction [asperuloside promotes the reaction [Cyclophosphamide results in increased lipidation of MAP1LC3B protein]] and dorsomorphin inhibits the reaction [Cyclophosphamide results in increased lipidation of MAP1LC3B protein] CTD PMID:38348709 MAP1LC3B Human dorsomorphin multiple interactions EXP 6480464 Alpha-Amanitin inhibits the reaction [dorsomorphin results in decreased lipidation of MAP1LC3B protein] more ... CTD PMID:23680031 more ... MAP1LC3B Human doxorubicin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Doxorubicin co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein more ... CTD PMID:32525084 and PMID:35134463 MAP1LC3B Human doxorubicin increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Doxorubicin results in increased lipidation of MAP1LC3B protein CTD PMID:35134463 MAP1LC3B Human doxorubicin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 SC-66 compound inhibits the reaction [SIRT4 protein inhibits the reaction [Doxorubicin results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:35134463 MAP1LC3B Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of MAP1LC3B mRNA and Doxorubicin results in increased expression of MAP1LC3B protein CTD PMID:29803840 and PMID:37406984 MAP1LC3B Human doxorubicin increases lipidation EXP 6480464 Doxorubicin results in increased lipidation of MAP1LC3B protein CTD PMID:26969377 MAP1LC3B Human doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Resveratrol] results in increased lipidation of MAP1LC3B protein and NORAD promotes the reaction [Doxorubicin results in increased expression of MAP1LC3B protein] CTD PMID:26969377 and PMID:37406984 MAP1LC3B Human EHT 1864 increases expression EXP 6480464 EHT 1864 results in increased expression of MAP1LC3B protein CTD PMID:35331739 MAP1LC3B Human elemental selenium multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of MAP1LC3B protein] CTD PMID:32233808 MAP1LC3B Human entinostat increases expression EXP 6480464 entinostat results in increased expression of MAP1LC3B protein modified form CTD PMID:20962572 MAP1LC3B Human enzalutamide multiple interactions EXP 6480464 [enzalutamide co-treated with GSK-2816126] results in increased expression of MAP1LC3B protein modified form CTD PMID:32805266 MAP1LC3B Human erastin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [erastin results in increased expression of MAP1LC3B protein modified form] and Chloroquine promotes the reaction [erastin results in increased expression of MAP1LC3B protein modified form] CTD PMID:32937103 MAP1LC3B Human erastin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 erastin results in increased expression of MAP1LC3B protein modified form CTD PMID:32937103 MAP1LC3B Human erlotinib hydrochloride multiple interactions EXP 6480464 Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:30136359 MAP1LC3B Human ethanol increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Ethanol results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 and PMID:36708882 MAP1LC3B Human ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of MAP1LC3B protein CTD PMID:34405320 MAP1LC3B Human ethanol decreases expression ISO Map1lc3b (Mus musculus) 6480464 Ethanol results in decreased expression of MAP1LC3B protein CTD PMID:34405320 MAP1LC3B Human ethanol increases expression ISO Map1lc3b (Mus musculus) 6480464 Ethanol results in increased expression of MAP1LC3B mRNA and Ethanol results in increased expression of MAP1LC3B protein CTD PMID:24095927 more ... MAP1LC3B Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of MAP1LC3B mRNA more ... CTD PMID:24095927 and PMID:29524503 MAP1LC3B Human ethanol multiple interactions EXP 6480464 Chloroquine promotes the reaction [Ethanol results in increased expression of MAP1LC3B protein] more ... CTD PMID:24095927 and PMID:34405320 MAP1LC3B Human ethanol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:24095927 more ... MAP1LC3B Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 MAP1LC3B Human everolimus multiple interactions EXP 6480464 Everolimus promotes the reaction [N-((1R and 2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:32397857 MAP1LC3B Human fangchinoline increases lipidation EXP 6480464 fangchinoline results in increased lipidation of MAP1LC3B protein CTD PMID:37689368 MAP1LC3B Human fenofibrate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Fenofibrate inhibits the reaction [tyloxapol results in increased lipidation of MAP1LC3B protein] CTD PMID:36905866 MAP1LC3B Human ferric ammonium citrate multiple interactions EXP 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein more ... CTD PMID:34826546 MAP1LC3B Human ferric oxide increases expression ISO Map1lc3b (Mus musculus) 6480464 ferric oxide analog results in increased expression of MAP1LC3B protein CTD PMID:24068039 MAP1LC3B Human ferrostatin-1 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein CTD PMID:35195477 MAP1LC3B Human finasteride increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Finasteride results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human flavokawain B multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:30025493 MAP1LC3B Human flavokawain B increases expression EXP 6480464 flavokawain B results in increased expression of MAP1LC3B protein modified form CTD PMID:30025493 MAP1LC3B Human flavonoids decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of MAP1LC3B mRNA CTD PMID:18035473 MAP1LC3B Human flutamide increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Flutamide results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human flutamide increases expression ISO Map1lc3b (Mus musculus) 6480464 Flutamide results in increased expression of MAP1LC3B mRNA CTD PMID:32662666 MAP1LC3B Human flutamide decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Flutamide results in decreased expression of MAP1LC3B protein CTD PMID:29606031 MAP1LC3B Human folic acid affects expression ISO Map1lc3b (Mus musculus) 6480464 Folic Acid affects the expression of MAP1LC3B mRNA CTD PMID:25629700 MAP1LC3B Human folic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3B mRNA CTD PMID:22206623 MAP1LC3B Human fomepizole multiple interactions ISO Map1lc3b (Mus musculus) 6480464 fomepizole inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] CTD PMID:24492484 MAP1LC3B Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 MAP1LC3B Human formaldehyde increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Formaldehyde results in increased expression of MAP1LC3B mRNA CTD PMID:24142868 MAP1LC3B Human fructose multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein] and [Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein CTD PMID:34939712 MAP1LC3B Human fumonisin B1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 fumonisin B1 results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:38705344 MAP1LC3B Human gamma-hexachlorocyclohexane increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased expression of MAP1LC3B mRNA CTD PMID:17785943 MAP1LC3B Human Garcinol multiple interactions EXP 6480464 garcinol inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3B protein] CTD PMID:36629037 MAP1LC3B Human gefitinib multiple interactions EXP 6480464 [MIR578 affects the susceptibility to Gefitinib] which affects the lipidation of MAP1LC3B protein and SOCS2 protein affects the reaction [[MIR578 affects the susceptibility to Gefitinib] which affects the lipidation of MAP1LC3B protein] CTD PMID:37948135 MAP1LC3B Human gingerol multiple interactions EXP 6480464 [gingerol co-treated with Hydrogen Peroxide] results in increased expression of MAP1LC3B protein modified form CTD PMID:27451028 MAP1LC3B Human Ginkgoic acid increases lipidation EXP 6480464 ginkgolic acid results in increased lipidation of MAP1LC3B protein CTD PMID:34132136 MAP1LC3B Human ginsenoside Rb1 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Cyclosporine inhibits the reaction [ginsenoside Rb1 promotes the reaction [alpha-Chlorohydrin results in increased lipidation of and results in increased localization of MAP1LC3B protein]] and ginsenoside Rb1 promotes the reaction [alpha-Chlorohydrin results in increased lipidation of and results in increased localization of MAP1LC3B protein] CTD PMID:38373586 MAP1LC3B Human ginsenoside Rb1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ginsenoside Rb1 promotes the reaction [alpha-Chlorohydrin results in increased lipidation of and results in increased localization of MAP1LC3B protein] CTD PMID:38373586 MAP1LC3B Human ginsenoside Rg2 multiple interactions EXP 6480464 bafilomycin A1 promotes the reaction [ginsenoside Rg2 results in increased expression of MAP1LC3B protein modified form] CTD PMID:27305347 MAP1LC3B Human ginsenoside Rg2 increases expression EXP 6480464 ginsenoside Rg2 results in increased expression of MAP1LC3B protein modified form CTD PMID:27305347 MAP1LC3B Human glafenine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glafenine results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human glucose decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in decreased expression of MAP1LC3B protein CTD PMID:29128638 MAP1LC3B Human glucose increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in increased expression of MAP1LC3B mRNA CTD PMID:38444079 MAP1LC3B Human glucose decreases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Glucose results in decreased lipidation of MAP1LC3B protein CTD PMID:35243728 MAP1LC3B Human glucose increases expression EXP 6480464 Glucose deficiency results in increased expression of MAP1LC3B protein and Glucose deficiency results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 MAP1LC3B Human glucose multiple interactions EXP 6480464 U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form] CTD PMID:34580807 MAP1LC3B Human glucose multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 more ... MAP1LC3B Human glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] and Glutathione inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:29247770 and PMID:34904774 MAP1LC3B Human glutathione increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Glutathione deficiency results in increased expression of MAP1LC3B mRNA CTD PMID:15345336 MAP1LC3B Human glycerol 2-phosphate multiple interactions EXP 6480464 MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA] and MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] CTD PMID:23111315 MAP1LC3B Human glycochenodeoxycholic acid decreases expression EXP 6480464 Glycochenodeoxycholic Acid results in decreased expression of MAP1LC3B mRNA CTD PMID:32439580 MAP1LC3B Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 and PMID:32439580 MAP1LC3B Human glycocholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 MAP1LC3B Human glycodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 MAP1LC3B Human glycyrrhizinic acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Glycyrrhizic Acid co-treated with bafilomycin A1] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:32525084 MAP1LC3B Human hesperidin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:34748272 more ... MAP1LC3B Human hexadecanoic acid affects localization ISO Map1lc3b (Mus musculus) 6480464 Palmitic Acid affects the localization of MAP1LC3B protein CTD PMID:30208301 MAP1LC3B Human hexadecanoic acid increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Palmitic Acid results in increased lipidation of MAP1LC3B protein CTD PMID:34774660 MAP1LC3B Human hexadecanoic acid increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Palmitic Acid results in increased expression of MAP1LC3B protein modified form CTD PMID:32278738 MAP1LC3B Human hexadecanoic acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 C1QTNF9 protein promotes the reaction [Palmitic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32278738 MAP1LC3B Human hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of MAP1LC3B mRNA and [Palmitic Acid co-treated with Oleic Acid] results in increased lipidation of MAP1LC3B protein CTD PMID:30547786 and PMID:36905866 MAP1LC3B Human Honokiol multiple interactions EXP 6480464 Sirolimus inhibits the reaction [honokiol results in increased lipidation of MAP1LC3B protein] CTD PMID:33550458 MAP1LC3B Human Honokiol increases lipidation EXP 6480464 honokiol results in increased lipidation of MAP1LC3B protein CTD PMID:33550458 MAP1LC3B Human hyaluronic acid increases cleavage ISO Map1lc3b (Rattus norvegicus) 6480464 Hyaluronic Acid results in increased cleavage of MAP1LC3B protein CTD PMID:27082295 MAP1LC3B Human hyaluronic acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of MAP1LC3B protein] CTD PMID:27082295 MAP1LC3B Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of MAP1LC3B mRNA CTD PMID:20044591 MAP1LC3B Human hydrogen peroxide multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 bafilomycin A1 inhibits the reaction [olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein]] and olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein] CTD PMID:36639873 MAP1LC3B Human hydrogen peroxide increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein CTD PMID:36639873 MAP1LC3B Human hydrogen peroxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA CTD PMID:27057282 MAP1LC3B Human hydrogen peroxide multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:27451028 more ... MAP1LC3B Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of MAP1LC3B mRNA more ... CTD PMID:23726866 and PMID:32043704 MAP1LC3B Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of MAP1LC3B protein alternative form CTD PMID:23726866 MAP1LC3B Human hydroquinone increases lipidation EXP 6480464 hydroquinone results in increased lipidation of MAP1LC3B protein CTD PMID:37148176 MAP1LC3B Human hydroquinone multiple interactions EXP 6480464 4 more ... CTD PMID:37148176 MAP1LC3B Human indoxyl sulfate increases expression ISO Map1lc3b (Mus musculus) 6480464 Indican results in increased expression of MAP1LC3B protein CTD PMID:30849338 MAP1LC3B Human indoxyl sulfate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of MAP1LC3B protein] CTD PMID:30849338 MAP1LC3B Human inositol multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Inositol inhibits the reaction [Glucose results in decreased lipidation of MAP1LC3B protein] CTD PMID:35243728 MAP1LC3B Human iron atom multiple interactions EXP 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein more ... CTD PMID:25301941 and PMID:34826546 MAP1LC3B Human iron(0) multiple interactions EXP 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein more ... CTD PMID:25301941 and PMID:34826546 MAP1LC3B Human isoliquiritigenin decreases expression ISO Map1lc3b (Mus musculus) 6480464 isoliquiritigenin results in decreased expression of MAP1LC3B protein CTD PMID:38311047 MAP1LC3B Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of MAP1LC3B protein CTD PMID:32959892 MAP1LC3B Human ivermectin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:34904774 MAP1LC3B Human JTE-013 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein] CTD PMID:37169277 MAP1LC3B Human juglone multiple interactions EXP 6480464 juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] CTD PMID:20479004 MAP1LC3B Human kainic acid multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32057834 MAP1LC3B Human kainic acid increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Kainic Acid results in increased expression of MAP1LC3B protein modified form CTD PMID:32057834 MAP1LC3B Human L-ascorbic acid 2-phosphate multiple interactions EXP 6480464 MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA] and MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] CTD PMID:23111315 MAP1LC3B Human L-leucine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:31676321 MAP1LC3B Human L-serine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [LAMC1 protein modified form co-treated with ANGPT1 protein co-treated with Serine] inhibits the reaction [beta-N-methylamino-L-alanine results in increased expression of MAP1LC3B protein] and Serine inhibits the reaction [beta-N-methylamino-L-alanine results in increased expression of MAP1LC3B protein] CTD PMID:30476904 MAP1LC3B Human lactucin multiple interactions EXP 6480464 lactucin results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:36364182 MAP1LC3B Human lactulose increases expression ISO Map1lc3b (Mus musculus) 6480464 Lactulose results in increased expression of MAP1LC3B mRNA CTD PMID:30335591 MAP1LC3B Human lanthanum trichloride increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 lanthanum chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:35090998 MAP1LC3B Human lanthanum trichloride increases expression EXP 6480464 lanthanum chloride results in increased expression of MAP1LC3B protein CTD PMID:38253231 MAP1LC3B Human lead diacetate multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:36652739 and PMID:36840722 MAP1LC3B Human lead(0) affects expression EXP 6480464 Lead affects the expression of MAP1LC3B mRNA CTD PMID:28903495 MAP1LC3B Human lead(0) multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:36652739 and PMID:36840722 MAP1LC3B Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of MAP1LC3B mRNA CTD PMID:28988120 MAP1LC3B Human leflunomide increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 leflunomide results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human levofloxacin multiple interactions EXP 6480464 [TNF protein co-treated with Levofloxacin] results in increased lipidation of MAP1LC3B protein and TNF protein promotes the reaction [Levofloxacin results in increased expression of MAP1LC3B protein] CTD PMID:33609687 MAP1LC3B Human levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of MAP1LC3B protein CTD PMID:33609687 MAP1LC3B Human lipopolysaccharide multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased lipidation of MAP1LC3B protein] and Sirolimus promotes the reaction [Lipopolysaccharides results in increased lipidation of MAP1LC3B protein] CTD PMID:37654027 MAP1LC3B Human lipopolysaccharide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [stearic acid co-treated with Lipopolysaccharides] affects the expression of MAP1LC3B protein more ... CTD PMID:33810233 and PMID:35099110 MAP1LC3B Human lipopolysaccharide affects localization ISO Map1lc3b (Mus musculus) 6480464 Lipopolysaccharides affects the localization of MAP1LC3B protein CTD PMID:35099110 MAP1LC3B Human lipopolysaccharide decreases expression ISO Map1lc3b (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of MAP1LC3B mRNA CTD PMID:35099110 MAP1LC3B Human lipopolysaccharide decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Lipopolysaccharides results in decreased expression of MAP1LC3B mRNA CTD PMID:34464015 MAP1LC3B Human lipopolysaccharide increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased lipidation of MAP1LC3B protein CTD PMID:37654027 MAP1LC3B Human luteolin multiple interactions EXP 6480464 Luteolin results in increased expression of and results in increased lipidation of MAP1LC3B protein and mirdametinib inhibits the reaction [Luteolin results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:32268164 MAP1LC3B Human LY294002 increases cleavage ISO Map1lc3b (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of MAP1LC3B protein CTD PMID:30611790 MAP1LC3B Human LY294002 multiple interactions EXP 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with pachastrissamine analog] results in increased lipidation of MAP1LC3B protein CTD PMID:35123989 MAP1LC3B Human LY294002 increases lipidation EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased lipidation of MAP1LC3B protein CTD PMID:35123989 MAP1LC3B Human LY294002 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [saikosaponin D results in decreased cleavage of MAP1LC3B protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [saikosaponin D results in increased expression of MAP1LC3B protein] CTD PMID:30611790 MAP1LC3B Human lycopene multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Glucose co-treated with Lycopene] results in increased expression of MAP1LC3B mRNA CTD PMID:38444079 MAP1LC3B Human lycopene multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased localization of MAP1LC3B protein] CTD PMID:36583613 MAP1LC3B Human manganese atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA and U 0126 inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA] CTD PMID:31690173 MAP1LC3B Human manganese(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA and U 0126 inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA] CTD PMID:31690173 MAP1LC3B Human manganese(II) chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA and U 0126 inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA] CTD PMID:31690173 MAP1LC3B Human melatonin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Atrazine results in increased expression of MAP1LC3B protein] more ... CTD PMID:25259610 more ... MAP1LC3B Human melibiose increases expression ISO Map1lc3b (Mus musculus) 6480464 Melibiose results in increased expression of MAP1LC3B mRNA CTD PMID:30335591 MAP1LC3B Human menadione multiple interactions EXP 6480464 [Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein and [S 3483 co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein CTD PMID:19819344 MAP1LC3B Human metformin multiple interactions EXP 6480464 [Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form and Chloroquine promotes the reaction [[Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form] CTD PMID:25412314 MAP1LC3B Human metformin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Metformin inhibits the reaction [Blood Glucose results in increased lipidation of MAP1LC3B protein] CTD PMID:33021114 MAP1LC3B Human methamphetamine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Methamphetamine results in increased lipidation of and affects the localization of MAP1LC3B protein and STX17 protein inhibits the reaction [Methamphetamine results in increased lipidation of MAP1LC3B protein] CTD PMID:34374793 MAP1LC3B Human methamphetamine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 6-formyl-5-isopropyl-3-hydroxymethyl-7-methyl-1H-indene inhibits the reaction [Methamphetamine results in increased expression of MAP1LC3B protein] more ... CTD PMID:31928234 and PMID:37567421 MAP1LC3B Human methamphetamine increases expression ISO Map1lc3b (Mus musculus) 6480464 Methamphetamine results in increased expression of MAP1LC3B protein CTD PMID:31928234 and PMID:37567421 MAP1LC3B Human methamphetamine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of MAP1LC3B mRNA CTD PMID:34374793 MAP1LC3B Human methimazole decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Methimazole results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 MAP1LC3B Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of MAP1LC3B mRNA CTD PMID:21678067 MAP1LC3B Human methotrexate multiple interactions EXP 6480464 [Methotrexate co-treated with theaflavin-3 and 3'-digallate] results in decreased expression of MAP1LC3B protein CTD PMID:34350509 MAP1LC3B Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of MAP1LC3B protein CTD PMID:34350509 MAP1LC3B Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 MAP1LC3B Human methylisothiazolinone multiple interactions EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of and results in increased cleavage of MAP1LC3B protein CTD PMID:29110394 MAP1LC3B Human methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MAP1LC3B protein CTD PMID:31629900 MAP1LC3B Human methylmercury chloride increases expression ISO Map1lc3b (Mus musculus) 6480464 methylmercuric chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:27667695 MAP1LC3B Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of MAP1LC3B mRNA more ... CTD PMID:27667695 more ... MAP1LC3B Human methylmercury chloride increases cleavage ISO Map1lc3b (Mus musculus) 6480464 methylmercuric chloride results in increased cleavage of MAP1LC3B protein CTD PMID:27667695 MAP1LC3B Human methylmercury chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of MAP1LC3B protein] and U 0126 inhibits the reaction [methylmercuric chloride results in increased expression of MAP1LC3B protein modified form] CTD PMID:27667695 MAP1LC3B Human methylphenidate decreases expression ISO Map1lc3b (Mus musculus) 6480464 Methylphenidate results in decreased expression of MAP1LC3B mRNA CTD PMID:22470460 MAP1LC3B Human methylphenidate increases expression ISO Map1lc3b (Mus musculus) 6480464 Methylphenidate results in increased expression of MAP1LC3B protein CTD PMID:32748667 MAP1LC3B Human methylphenidate increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Methylphenidate results in increased expression of MAP1LC3B mRNA CTD PMID:32746681 MAP1LC3B Human metyrapone multiple interactions EXP 6480464 [Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein CTD PMID:19819344 MAP1LC3B Human miconazole increases lipidation EXP 6480464 Miconazole results in increased lipidation of MAP1LC3B protein CTD PMID:32981224 MAP1LC3B Human miconazole multiple interactions EXP 6480464 [bafilomycin A1 co-treated with Miconazole] results in increased expression of MAP1LC3B protein and bafilomycin A1 promotes the reaction [Miconazole results in increased lipidation of MAP1LC3B protein] CTD PMID:32981224 MAP1LC3B Human mitoxantrone multiple interactions EXP 6480464 Mitoxantrone results in decreased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:36216988 MAP1LC3B Human MJN110 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 MJN110 affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein] CTD PMID:30301768 MAP1LC3B Human MJN110 increases lipidation ISO Map1lc3b (Mus musculus) 6480464 MJN110 results in increased lipidation of MAP1LC3B protein CTD PMID:30301768 MAP1LC3B Human MK-2206 multiple interactions EXP 6480464 MK 2206 promotes the reaction [butein results in increased lipidation of MAP1LC3B protein] CTD PMID:35130734 MAP1LC3B Human mono(2-ethylhexyl) phthalate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased localization of MAP1LC3B protein CTD PMID:37692514 MAP1LC3B Human mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of MAP1LC3B mRNA and mono-(2-ethylhexyl)phthalate results in increased expression of MAP1LC3B protein CTD PMID:38522500 MAP1LC3B Human mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 RAP1A protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MAP1LC3B mRNA] and RAP1A protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MAP1LC3B protein] CTD PMID:38522500 MAP1LC3B Human myriocin multiple interactions EXP 6480464 thermozymocidin inhibits the reaction [Dronabinol results in increased expression of and affects the localization of and affects the lipidation of MAP1LC3B protein] CTD PMID:27635674 MAP1LC3B Human N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 MAP1LC3B Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [2' more ... CTD PMID:20543569 more ... MAP1LC3B Human N-acetyl-L-cysteine increases expression EXP 6480464 Acetylcysteine results in increased expression of MAP1LC3B protein and Acetylcysteine results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 MAP1LC3B Human N-acetyl-L-cysteine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:30849338 more ... MAP1LC3B Human N-acetyl-L-cysteine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] more ... CTD PMID:27832966 and PMID:28347754 MAP1LC3B Human N-acylsphinganine multiple interactions EXP 6480464 dihydroceramide analog results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32397857 MAP1LC3B Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MAP1LC3B protein modified form CTD PMID:26409479 MAP1LC3B Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein] and MAP1LC3B protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of NFKBIA protein] CTD PMID:24085292 and PMID:33609687 MAP1LC3B Human N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:36078115 more ... MAP1LC3B Human N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3B protein CTD PMID:36629037 MAP1LC3B Human NADP zwitterion multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32057834 MAP1LC3B Human NADP(+) multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32057834 MAP1LC3B Human Naftopidil affects expression EXP 6480464 naftopidil affects the expression of MAP1LC3B protein CTD PMID:29374705 MAP1LC3B Human nefazodone increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 nefazodone results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA and nefazodone results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32152650 and PMID:33609687 MAP1LC3B Human nefazodone increases expression EXP 6480464 nefazodone results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 MAP1LC3B Human nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of MAP1LC3B protein CTD PMID:20594311 MAP1LC3B Human nelfinavir multiple interactions EXP 6480464 Tamoxifen promotes the reaction [Nelfinavir results in increased expression of MAP1LC3B protein] CTD PMID:20594311 MAP1LC3B Human nickel dichloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [nickel chloride results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:36421005 MAP1LC3B Human nickel dichloride increases expression ISO Map1lc3b (Mus musculus) 6480464 nickel chloride results in increased expression of MAP1LC3B mRNA CTD PMID:36421005 MAP1LC3B Human niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of MAP1LC3B protein modified form CTD PMID:30258081 MAP1LC3B Human nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] CTD PMID:24145604 MAP1LC3B Human nimesulide increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 nimesulide results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 MAP1LC3B Human Nivalenol decreases expression ISO Map1lc3b (Mus musculus) 6480464 nivalenol results in decreased expression of MAP1LC3B mRNA CTD PMID:35016910 MAP1LC3B Human Nonylphenol increases cleavage ISO Map1lc3b (Rattus norvegicus) 6480464 nonylphenol results in increased cleavage of MAP1LC3B protein CTD PMID:27832966 MAP1LC3B Human Nonylphenol affects expression ISO Map1lc3b (Rattus norvegicus) 6480464 nonylphenol affects the expression of MAP1LC3B protein CTD PMID:27832966 MAP1LC3B Human Nonylphenol multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [nonylphenol results in increased expression of MAP1LC3B protein] CTD PMID:27832966 MAP1LC3B Human obeticholic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of MAP1LC3B protein] CTD PMID:26655953 MAP1LC3B Human ochratoxin A multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of MAP1LC3B protein] CTD PMID:36058351 MAP1LC3B Human ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of MAP1LC3B protein CTD PMID:36058351 MAP1LC3B Human octadecanoic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [stearic acid co-treated with Lipopolysaccharides] affects the expression of MAP1LC3B protein CTD PMID:33810233 MAP1LC3B Human octreotide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein] more ... CTD PMID:35307376 MAP1LC3B Human olaparib multiple interactions EXP 6480464 Chloroquine promotes the reaction [olaparib promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:34826546 MAP1LC3B Human olaparib multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 bafilomycin A1 inhibits the reaction [olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein]] and olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein] CTD PMID:36639873 MAP1LC3B Human oleanolic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of MAP1LC3B protein] CTD PMID:31306688 MAP1LC3B Human oleanolic acid multiple interactions EXP 6480464 Cisplatin promotes the reaction [Oleanolic Acid results in increased expression of MAP1LC3B protein] more ... CTD PMID:31306688 and PMID:35690101 MAP1LC3B Human oleanolic acid increases expression EXP 6480464 Oleanolic Acid results in increased expression of MAP1LC3B protein CTD PMID:31306688 MAP1LC3B Human oleic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of MAP1LC3B mRNA and [Palmitic Acid co-treated with Oleic Acid] results in increased lipidation of MAP1LC3B protein CTD PMID:30547786 and PMID:36905866 MAP1LC3B Human Ophiopogonin D increases expression EXP 6480464 ophiopogonin D results in increased expression of MAP1LC3B protein CTD PMID:35905946 MAP1LC3B Human Ophiopogonin D multiple interactions EXP 6480464 3-(2 and 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in increased expression of MAP1LC3B protein] CTD PMID:35905946 MAP1LC3B Human osthole multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [osthol inhibits the reaction [Antineoplastic Agents more ... CTD PMID:37769856 MAP1LC3B Human oxidopamine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Oxidopamine results in increased expression of MAP1LC3B protein modified form CTD PMID:28802652 MAP1LC3B Human ozone increases expression ISO Map1lc3b (Mus musculus) 6480464 Ozone results in increased expression of MAP1LC3B protein CTD PMID:35866636 MAP1LC3B Human paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of MAP1LC3B mRNA and Paclitaxel results in increased expression of MAP1LC3B protein CTD PMID:19815708 MAP1LC3B Human paclitaxel increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Paclitaxel results in increased expression of MAP1LC3B mRNA CTD PMID:35921949 MAP1LC3B Human paclitaxel multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAP1LC3B mRNA] CTD PMID:35921949 MAP1LC3B Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP1LC3B mRNA CTD PMID:21420995 and PMID:29067470 MAP1LC3B Human paracetamol increases expression ISO Map1lc3b (Mus musculus) 6480464 Acetaminophen results in increased expression of MAP1LC3B mRNA CTD PMID:37179516 MAP1LC3B Human paracetamol increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of MAP1LC3B protein CTD PMID:28682524 MAP1LC3B Human paracetamol multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein] CTD PMID:28682524 MAP1LC3B Human paraformaldehyde macromolecule multiple interactions ISO Map1lc3b (Mus musculus) 6480464 GDF11 protein promotes the reaction [sodium bisulfide inhibits the reaction [paraform results in increased expression of MAP1LC3B protein]] and sodium bisulfide inhibits the reaction [paraform results in increased expression of MAP1LC3B protein] CTD PMID:37105376 MAP1LC3B Human paraformaldehyde macromolecule increases expression ISO Map1lc3b (Mus musculus) 6480464 paraform results in increased expression of MAP1LC3B protein CTD PMID:37105376 MAP1LC3B Human paraquat multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [ST2825 co-treated with Paraquat] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:27246695 more ... MAP1LC3B Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of MAP1LC3B mRNA CTD PMID:27220436 MAP1LC3B Human paraquat multiple interactions EXP 6480464 Paraquat inhibits the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] CTD PMID:26409479 MAP1LC3B Human paraquat increases expression ISO Map1lc3b (Mus musculus) 6480464 Paraquat results in increased expression of MAP1LC3B protein CTD PMID:25092649 more ... MAP1LC3B Human parthenolide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 parthenolide inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of MAP1LC3B protein] CTD PMID:37858773 MAP1LC3B Human PD 0325901 multiple interactions EXP 6480464 mirdametinib inhibits the reaction [Luteolin results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:32268164 MAP1LC3B Human pectolinarigenin multiple interactions EXP 6480464 Chloroquine promotes the reaction [pectolinarigenin results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:37393350 MAP1LC3B Human pectolinarigenin increases lipidation EXP 6480464 pectolinarigenin results in increased lipidation of MAP1LC3B protein CTD PMID:37393350 MAP1LC3B Human Pentoxifylline multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MAP1LC3B protein modified form] CTD PMID:32777238 MAP1LC3B Human pepstatin A multiple interactions EXP 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:21184746 more ... MAP1LC3B Human pepstatin A multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:26483381 and PMID:27635674 MAP1LC3B Human perfluorobutyric acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with perfluorobutyric acid co-treated with perfluorotetradecanoic acid] results in increased expression of MAP1LC3B protein CTD PMID:37806615 MAP1LC3B Human perfluorooctane-1-sulfonic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of MAP1LC3B protein modified form CTD PMID:32861759 MAP1LC3B Human perfluorooctane-1-sulfonic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP1LC3B mRNA CTD PMID:36331819 MAP1LC3B Human perfluorooctanoic acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with perfluorobutyric acid co-treated with perfluorotetradecanoic acid] results in increased expression of MAP1LC3B protein and ATG5 protein promotes the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:26879310 and PMID:37806615 MAP1LC3B Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3B mRNA and perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form CTD PMID:26879310 and PMID:37806615 MAP1LC3B Human perfluorooctanoic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3B mRNA and perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form CTD PMID:26879310 MAP1LC3B Human perfluoroundecanoic acid increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 perfluoroundecanoic acid results in increased expression of MAP1LC3B protein CTD PMID:33549592 MAP1LC3B Human permethrin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Permethrin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:38040083 MAP1LC3B Human phenobarbital increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of MAP1LC3B mRNA CTD PMID:19162173 MAP1LC3B Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of MAP1LC3B mRNA CTD PMID:19159669 MAP1LC3B Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] more ... CTD PMID:20479004 MAP1LC3B Human phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein CTD PMID:20479004 MAP1LC3B Human phosphatidylethanolamine multiple interactions EXP 6480464 calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] and dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine] CTD PMID:19848398 MAP1LC3B Human pirinixic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP1LC3B mRNA] CTD PMID:21318169 MAP1LC3B Human pirinixic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 pirinixic acid results in increased expression of MAP1LC3B mRNA CTD PMID:18301758 more ... MAP1LC3B Human platycodin D increases expression EXP 6480464 platycodin D results in increased expression of MAP1LC3B mRNA and platycodin D results in increased expression of MAP1LC3B protein CTD PMID:26078792 MAP1LC3B Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAP1LC3B mRNA CTD PMID:22079256 MAP1LC3B Human potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of MAP1LC3B mRNA CTD PMID:22079256 and PMID:22714537 MAP1LC3B Human potassium dichromate multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Potassium Dichromate results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:36416502 MAP1LC3B Human pregnenolone 16alpha-carbonitrile increases expression ISO Map1lc3b (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of MAP1LC3B mRNA CTD PMID:28903501 MAP1LC3B Human procyanidin B2 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Diquat co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA and [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA CTD PMID:27057282 MAP1LC3B Human pterostilbene multiple interactions EXP 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] CTD PMID:34405320 MAP1LC3B Human pterostilbene multiple interactions ISO Map1lc3b (Mus musculus) 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] CTD PMID:34405320 MAP1LC3B Human puerarin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 puerarin inhibits the reaction [cadmium acetate results in decreased expression of MAP1LC3B protein modified form] CTD PMID:34897960 MAP1LC3B Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of MAP1LC3B mRNA and Quercetin results in increased expression of MAP1LC3B protein CTD PMID:21632981 and PMID:28251795 MAP1LC3B Human quercetin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Quercetin co-treated with crocin] inhibits the reaction [Blood Glucose results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:32347499 more ... MAP1LC3B Human quercetin increases cleavage EXP 6480464 Quercetin results in increased cleavage of MAP1LC3B protein CTD PMID:28251795 MAP1LC3B Human quercetin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Quercetin results in increased cleavage of MAP1LC3B protein] and benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Quercetin results in increased cleavage of MAP1LC3B protein] CTD PMID:28251795 MAP1LC3B Human quetiapine fumarate decreases metabolic processing ISO Map1lc3b (Mus musculus) 6480464 Quetiapine Fumarate results in decreased metabolism of MAP1LC3B protein CTD PMID:31220554 MAP1LC3B Human rac-1-monopalmitoylglycerol increases lipidation EXP 6480464 palmitoyl glycerol results in increased lipidation of MAP1LC3B protein CTD PMID:37466199 MAP1LC3B Human rac-1-monopalmitoylglycerol multiple interactions EXP 6480464 Chloroquine promotes the reaction [palmitoyl glycerol results in increased lipidation of MAP1LC3B protein] CTD PMID:37466199 MAP1LC3B Human radon atom increases expression ISO Map1lc3b (Mus musculus) 6480464 Radon results in increased expression of MAP1LC3B protein CTD PMID:33107683 MAP1LC3B Human radon atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Radon results in increased expression of MAP1LC3B protein] CTD PMID:33107683 MAP1LC3B Human radon(0) increases expression ISO Map1lc3b (Mus musculus) 6480464 Radon results in increased expression of MAP1LC3B protein CTD PMID:33107683 MAP1LC3B Human radon(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Radon results in increased expression of MAP1LC3B protein] CTD PMID:33107683 MAP1LC3B Human raloxifene increases lipidation EXP 6480464 Raloxifene Hydrochloride results in increased lipidation of MAP1LC3B protein CTD PMID:33203845 MAP1LC3B Human raloxifene multiple interactions EXP 6480464 [Raloxifene Hydrochloride co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein CTD PMID:33203845 MAP1LC3B Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MAP1LC3B mRNA and resveratrol results in increased expression of MAP1LC3B protein alternative form CTD PMID:23750556 and PMID:24145604 MAP1LC3B Human resveratrol increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Resveratrol results in increased lipidation of MAP1LC3B protein CTD PMID:32619457 MAP1LC3B Human resveratrol increases lipidation EXP 6480464 resveratrol results in increased lipidation of MAP1LC3B protein CTD PMID:26969377 MAP1LC3B Human resveratrol multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with Resveratrol] promotes the reaction [MAP1LC3B protein binds to TOMM20 protein] more ... CTD PMID:32619457 MAP1LC3B Human resveratrol increases expression ISO Map1lc3b (Mus musculus) 6480464 resveratrol results in increased expression of MAP1LC3B mRNA CTD PMID:24095927 MAP1LC3B Human resveratrol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 resveratrol promotes the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] CTD PMID:24095927 MAP1LC3B Human resveratrol multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form] more ... CTD PMID:23680031 more ... MAP1LC3B Human resveratrol affects metabolic processing EXP 6480464 resveratrol affects the metabolism of MAP1LC3B protein CTD PMID:23680031 MAP1LC3B Human rifampicin decreases metabolic processing EXP 6480464 Rifampin results in decreased metabolism of MAP1LC3B protein CTD PMID:29908302 MAP1LC3B Human rifampicin increases lipidation EXP 6480464 Rifampin results in increased lipidation of MAP1LC3B protein CTD PMID:31648047 MAP1LC3B Human rifampicin multiple interactions EXP 6480464 ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:31648047 MAP1LC3B Human rimonabant multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Rimonabant results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:31570772 MAP1LC3B Human rotenone decreases expression ISO Map1lc3b (Mus musculus) 6480464 Rotenone results in decreased expression of MAP1LC3B mRNA CTD PMID:23186747 MAP1LC3B Human rotenone decreases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Rotenone results in decreased lipidation of MAP1LC3B protein CTD PMID:35104487 MAP1LC3B Human rotenone multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]] and Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein] CTD PMID:35104487 MAP1LC3B Human rotenone multiple interactions EXP 6480464 4 more ... CTD PMID:30673822 more ... MAP1LC3B Human rotenone increases lipidation EXP 6480464 Rotenone results in increased lipidation of MAP1LC3B protein CTD PMID:31648047 and PMID:37156403 MAP1LC3B Human rotenone increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Rotenone results in increased expression of MAP1LC3B mRNA CTD PMID:28374803 MAP1LC3B Human rotenone multiple interactions ISO Map1lc3b (Mus musculus) 6480464 wortmannin inhibits the reaction [Rotenone results in increased expression of MAP1LC3B protein] CTD PMID:26847702 MAP1LC3B Human rotenone increases expression ISO Map1lc3b (Mus musculus) 6480464 Rotenone results in increased expression of MAP1LC3B protein CTD PMID:26847702 MAP1LC3B Human roxadustat multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of MAP1LC3B protein] CTD PMID:27082295 MAP1LC3B Human ruthenium red multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased lipidation of MAP1LC3B protein] CTD PMID:34308505 MAP1LC3B Human S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein] and Cadmium Chloride promotes the reaction [Buthionine Sulfoximine results in increased expression of MAP1LC3B protein] CTD PMID:34580807 MAP1LC3B Human S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of MAP1LC3B protein and Buthionine Sulfoximine results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 MAP1LC3B Human SB 203580 multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 SB 203580 inhibits the reaction [osthol inhibits the reaction [Antineoplastic Agents and Immunological results in decreased lipidation of MAP1LC3B protein]] CTD PMID:37769856 MAP1LC3B Human SB 203580 multiple interactions EXP 6480464 SB 203580 promotes the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:34861471 MAP1LC3B Human SCH772984 multiple interactions EXP 6480464 SCH772984 inhibits the reaction [pachastrissamine analog results in increased lipidation of MAP1LC3B protein] CTD PMID:35123989 MAP1LC3B Human selenium atom multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of MAP1LC3B protein] CTD PMID:32233808 MAP1LC3B Human selenomethionine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Selenomethionine inhibits the reaction [deoxynivalenol results in decreased expression of MAP1LC3B protein] CTD PMID:38040082 MAP1LC3B Human sepantronium multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [sepantronium results in increased lipidation of MAP1LC3B protein] and Chloroquine promotes the reaction [sepantronium results in increased lipidation of MAP1LC3B protein] CTD PMID:31837377 MAP1LC3B Human sepantronium increases lipidation EXP 6480464 sepantronium results in increased lipidation of MAP1LC3B protein CTD PMID:31837377 MAP1LC3B Human serpentine asbestos increases expression EXP 6480464 Asbestos and Serpentine results in increased expression of MAP1LC3B mRNA CTD PMID:24735948 MAP1LC3B Human sertraline increases lipidation EXP 6480464 Sertraline results in increased lipidation of MAP1LC3B protein CTD PMID:33124469 MAP1LC3B Human sertraline multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Sertraline results in increased lipidation of MAP1LC3B protein] CTD PMID:33124469 MAP1LC3B Human sevoflurane decreases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Sevoflurane results in decreased lipidation of MAP1LC3B protein CTD PMID:34590382 MAP1LC3B Human sevoflurane multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sevoflurane results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35472370 MAP1LC3B Human sevoflurane increases lipidation EXP 6480464 Sevoflurane results in increased lipidation of MAP1LC3B protein CTD PMID:35472370 MAP1LC3B Human sevoflurane decreases expression ISO Map1lc3b (Mus musculus) 6480464 Sevoflurane results in decreased expression of MAP1LC3B protein CTD PMID:35249202 MAP1LC3B Human sevoflurane multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Dexmedetomidine inhibits the reaction [Sevoflurane results in decreased lipidation of MAP1LC3B protein] more ... CTD PMID:34590382 and PMID:36177783 MAP1LC3B Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of MAP1LC3B mRNA and Silicon Dioxide analog results in increased expression of MAP1LC3B protein CTD PMID:23806026 and PMID:25895662 MAP1LC3B Human silicon dioxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 GAS6 gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of MAP1LC3B protein modified form] and MERTK gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of MAP1LC3B protein modified form] CTD PMID:33232774 MAP1LC3B Human silicon dioxide increases expression ISO Map1lc3b (Mus musculus) 6480464 Silicon Dioxide analog results in increased expression of MAP1LC3B protein alternative form more ... CTD PMID:19073995 more ... MAP1LC3B Human silver atom increases expression EXP 6480464 Silver results in increased expression of MAP1LC3B mRNA and Silver results in increased expression of MAP1LC3B protein modified form CTD PMID:26014281 and PMID:28987793 MAP1LC3B Human silver(0) increases expression EXP 6480464 Silver results in increased expression of MAP1LC3B mRNA and Silver results in increased expression of MAP1LC3B protein modified form CTD PMID:26014281 and PMID:28987793 MAP1LC3B Human simvastatin increases expression ISO Map1lc3b (Mus musculus) 6480464 Simvastatin results in increased expression of MAP1LC3B protein CTD PMID:23817226 MAP1LC3B Human simvastatin multiple interactions EXP 6480464 [Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form and Chloroquine promotes the reaction [[Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form] CTD PMID:25412314 MAP1LC3B Human sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of MAP1LC3B mRNA more ... CTD PMID:19815708 more ... MAP1LC3B Human sirolimus increases lipidation EXP 6480464 Sirolimus results in increased lipidation of MAP1LC3B protein CTD PMID:34281243 more ... MAP1LC3B Human sirolimus increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Sirolimus results in increased lipidation of MAP1LC3B protein CTD PMID:29793971 MAP1LC3B Human sirolimus multiple interactions EXP 6480464 [bisphenol A co-treated with Sirolimus] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29518472 more ... MAP1LC3B Human sirolimus affects metabolic processing EXP 6480464 Sirolimus affects the metabolism of MAP1LC3B protein CTD PMID:23680031 MAP1LC3B Human sirolimus multiple interactions ISO Map1lc3b (Mus musculus) 6480464 CD38 gene mutant form promotes the reaction [Sirolimus results in increased expression of MAP1LC3B protein] more ... CTD PMID:24445604 more ... MAP1LC3B Human sirolimus increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Sirolimus results in increased expression of MAP1LC3B mRNA and Sirolimus results in increased expression of MAP1LC3B protein modified form CTD PMID:18640276 and PMID:30611790 MAP1LC3B Human sirolimus multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:18640276 more ... MAP1LC3B Human sirolimus affects localization ISO Map1lc3b (Rattus norvegicus) 6480464 Sirolimus affects the localization of MAP1LC3B protein CTD PMID:18640276 MAP1LC3B Human sirolimus increases expression ISO Map1lc3b (Mus musculus) 6480464 Sirolimus results in increased expression of MAP1LC3B mRNA more ... CTD PMID:21681844 more ... MAP1LC3B Human sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32525701 MAP1LC3B Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MAP1LC3B mRNA and sodium arsenite results in increased expression of MAP1LC3B protein CTD PMID:19577553 more ... MAP1LC3B Human sodium arsenite affects expression ISO Map1lc3b (Mus musculus) 6480464 sodium arsenite affects the expression of MAP1LC3B mRNA CTD PMID:36557995 MAP1LC3B Human sodium arsenite increases lipidation ISO Map1lc3b (Mus musculus) 6480464 sodium arsenite results in increased lipidation of MAP1LC3B protein CTD PMID:38387523 MAP1LC3B Human sodium arsenite decreases expression ISO Map1lc3b (Mus musculus) 6480464 sodium arsenite results in decreased expression of MAP1LC3B mRNA CTD PMID:38387523 MAP1LC3B Human sodium arsenite multiple interactions ISO Map1lc3b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3B mRNA]] more ... CTD PMID:26483381 more ... MAP1LC3B Human sodium arsenite increases lipidation EXP 6480464 sodium arsenite results in increased lipidation of MAP1LC3B protein CTD PMID:36958258 MAP1LC3B Human sodium arsenite multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP1LC3B mRNA CTD PMID:31844926 MAP1LC3B Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MAP1LC3B mRNA CTD PMID:28595984 and PMID:34032870 MAP1LC3B Human sodium arsenite increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 sodium arsenite results in increased expression of MAP1LC3B protein CTD PMID:26432159 MAP1LC3B Human sodium arsenite decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of MAP1LC3B mRNA CTD PMID:19072884 MAP1LC3B Human sodium arsenite increases expression ISO Map1lc3b (Mus musculus) 6480464 sodium arsenite results in increased expression of MAP1LC3B protein CTD PMID:27413109 and PMID:38579892 MAP1LC3B Human sodium arsenite multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:19577553 more ... MAP1LC3B Human sodium fluoride increases expression ISO Map1lc3b (Mus musculus) 6480464 Sodium Fluoride results in increased expression of MAP1LC3B mRNA and Sodium Fluoride results in increased expression of MAP1LC3B protein CTD PMID:29505816 more ... MAP1LC3B Human sodium fluoride increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Sodium Fluoride results in increased expression of MAP1LC3B protein CTD PMID:35413380 MAP1LC3B Human sodium fluoride multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:31844926 and PMID:35413380 MAP1LC3B Human sodium fluoride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 TGFB1 protein promotes the reaction [Sodium Fluoride results in increased expression of MAP1LC3B mRNA] CTD PMID:29505816 MAP1LC3B Human Soman increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Soman results in increased expression of MAP1LC3B mRNA CTD PMID:19281266 MAP1LC3B Human sphingosine 1-phosphate multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:37169277 MAP1LC3B Human sphingosine 1-phosphate increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 sphingosine 1-phosphate results in increased expression of MAP1LC3B mRNA CTD PMID:37169277 MAP1LC3B Human spironolactone increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Spironolactone results in increased expression of MAP1LC3B protein CTD PMID:30734886 MAP1LC3B Human stattic multiple interactions EXP 6480464 stattic results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:38460807 MAP1LC3B Human streptozocin decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Streptozocin results in decreased expression of MAP1LC3B mRNA CTD PMID:37352119 MAP1LC3B Human streptozocin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of MAP1LC3B mRNA more ... CTD PMID:32233808 more ... MAP1LC3B Human streptozocin increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Streptozocin results in increased lipidation of MAP1LC3B protein CTD PMID:38706688 MAP1LC3B Human streptozocin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Streptozocin results in increased expression of MAP1LC3B protein CTD PMID:32233808 MAP1LC3B Human sulfadimethoxine decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Sulfadimethoxine results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 MAP1LC3B Human sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of MAP1LC3B mRNA CTD PMID:32111854 MAP1LC3B Human sulforaphane multiple interactions ISO Map1lc3b (Mus musculus) 6480464 sulforaphane inhibits the reaction [Methamphetamine results in increased expression of MAP1LC3B protein] CTD PMID:37567421 MAP1LC3B Human sulfur dioxide multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein] CTD PMID:30503585 MAP1LC3B Human swainsonine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Swainsonine results in increased expression of MAP1LC3B protein CTD PMID:38579922 MAP1LC3B Human swainsonine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Swainsonine results in increased localization of and results in increased lipidation of MAP1LC3B protein CTD PMID:37442287 MAP1LC3B Human swainsonine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA and [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of MAP1LC3B protein CTD PMID:36402259 MAP1LC3B Human swainsonine increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Swainsonine results in increased lipidation of MAP1LC3B protein CTD PMID:36402259 MAP1LC3B Human swainsonine increases expression ISO Map1lc3b (Mus musculus) 6480464 Swainsonine results in increased expression of MAP1LC3B mRNA CTD PMID:36402259 MAP1LC3B Human T-2 toxin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 T-2 Toxin results in increased expression of and results in increased cleavage of MAP1LC3B protein CTD PMID:29413859 MAP1LC3B Human T-2 toxin affects expression ISO Map1lc3b (Mus musculus) 6480464 T-2 Toxin affects the expression of MAP1LC3B protein CTD PMID:36402210 MAP1LC3B Human T-2 toxin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of MAP1LC3B protein] CTD PMID:36402210 MAP1LC3B Human T-2 toxin increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 T-2 Toxin results in increased expression of MAP1LC3B mRNA CTD PMID:29413859 MAP1LC3B Human tamoxifen decreases response to substance EXP 6480464 MAP1LC3B protein results in decreased susceptibility to Tamoxifen CTD PMID:20479004 MAP1LC3B Human tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of MAP1LC3B protein CTD PMID:25301941 MAP1LC3B Human tamoxifen affects expression ISO Map1lc3b (Mus musculus) 6480464 Tamoxifen affects the expression of MAP1LC3B mRNA CTD PMID:17555576 MAP1LC3B Human tamoxifen multiple interactions EXP 6480464 Tamoxifen promotes the reaction [Nelfinavir results in increased expression of MAP1LC3B protein] CTD PMID:20594311 MAP1LC3B Human Tartrolon D increases lipidation EXP 6480464 tartrolon D results in increased lipidation of MAP1LC3B protein CTD PMID:39097071 MAP1LC3B Human Tartrolon D increases lipidation ISO Map1lc3b (Mus musculus) 6480464 tartrolon D results in increased lipidation of MAP1LC3B protein CTD PMID:39097071 MAP1LC3B Human taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 MAP1LC3B Human taurine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 MAP1LC3B Human taurocholic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Taurocholic Acid results in increased expression of MAP1LC3B protein CTD PMID:24189133 MAP1LC3B Human tebufenpyrad increases expression EXP 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 MAP1LC3B Human temozolomide increases expression EXP 6480464 temozolomide results in increased expression of MAP1LC3B protein CTD PMID:19567134 MAP1LC3B Human temozolomide multiple interactions EXP 6480464 Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] CTD PMID:19567134 MAP1LC3B Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA CTD PMID:15336504 MAP1LC3B Human testosterone multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1LC3B mRNA] CTD PMID:20032058 MAP1LC3B Human tetrachloromethane affects expression ISO Map1lc3b (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of MAP1LC3B mRNA CTD PMID:17484886 MAP1LC3B Human tetrachloromethane increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Carbon Tetrachloride results in increased lipidation of MAP1LC3B protein CTD PMID:35405287 MAP1LC3B Human tetrachloromethane multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Sirolimus inhibits the reaction [Carbon Tetrachloride results in increased lipidation of MAP1LC3B protein] CTD PMID:35405287 MAP1LC3B Human thalidomide multiple interactions EXP 6480464 Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] CTD PMID:19567134 MAP1LC3B Human thapsigargin multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Thapsigargin affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein] more ... CTD PMID:28347754 MAP1LC3B Human thapsigargin multiple interactions EXP 6480464 Thapsigargin promotes the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein modified form] CTD PMID:25639782 MAP1LC3B Human Theaflavin 3,3'-digallate decreases expression EXP 6480464 theaflavin-3 and 3'-digallate results in decreased expression of MAP1LC3B protein CTD PMID:34350509 MAP1LC3B Human Theaflavin 3,3'-digallate multiple interactions EXP 6480464 [Methotrexate co-treated with theaflavin-3 and 3'-digallate] results in decreased expression of MAP1LC3B protein CTD PMID:34350509 MAP1LC3B Human thiamine(1+) chloride multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 MAP1LC3B Human thiamine(1+) chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 MAP1LC3B Human thifluzamide increases expression EXP 6480464 thifluzamide results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 MAP1LC3B Human thioacetamide decreases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of MAP1LC3B mRNA CTD PMID:34492290 MAP1LC3B Human thiram increases expression EXP 6480464 Thiram results in increased expression of MAP1LC3B mRNA CTD PMID:38568856 MAP1LC3B Human titanium dioxide increases lipidation EXP 6480464 titanium dioxide results in increased lipidation of MAP1LC3B protein CTD PMID:31927068 MAP1LC3B Human titanium dioxide decreases methylation ISO Map1lc3b (Mus musculus) 6480464 titanium dioxide results in decreased methylation of MAP1LC3B gene more ... CTD PMID:35295148 MAP1LC3B Human titanium dioxide increases expression ISO Map1lc3b (Mus musculus) 6480464 titanium dioxide analog results in increased expression of MAP1LC3B protein and titanium dioxide results in increased expression of MAP1LC3B mRNA CTD PMID:25111187 and PMID:29792337 MAP1LC3B Human toosendanin multiple interactions EXP 6480464 IL6 protein inhibits the reaction [toosendanin results in increased lipidation of and results in increased localization of MAP1LC3B protein] more ... CTD PMID:38460807 MAP1LC3B Human toosendanin increases lipidation EXP 6480464 toosendanin analog results in increased lipidation of MAP1LC3B protein and toosendanin results in increased lipidation of MAP1LC3B protein CTD PMID:34742683 MAP1LC3B Human toosendanin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 STAT3 protein inhibits the reaction [toosendanin results in increased lipidation of and results in increased localization of MAP1LC3B protein] and toosendanin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:38460807 MAP1LC3B Human trametinib multiple interactions EXP 6480464 trametinib affects the expression of and affects the lipidation of MAP1LC3B protein CTD PMID:30339727 MAP1LC3B Human tricalcium bis(phosphate) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [tricalcium phosphate affects the localization of MAP1LC3B protein] and bafilomycin A1 promotes the reaction [tricalcium phosphate results in increased expression of MAP1LC3B protein] CTD PMID:37678662 MAP1LC3B Human tricalcium bis(phosphate) affects localization ISO Map1lc3b (Mus musculus) 6480464 tricalcium phosphate affects the localization of MAP1LC3B protein CTD PMID:37678662 MAP1LC3B Human trichostatin A affects localization EXP 6480464 trichostatin A affects the localization of MAP1LC3B protein modified form CTD PMID:20543569 MAP1LC3B Human trichostatin A multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine promotes the reaction [trichostatin A results in increased expression of MAP1LC3B protein modified form] CTD PMID:29476062 MAP1LC3B Human trichostatin A increases expression ISO Map1lc3b (Mus musculus) 6480464 trichostatin A results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 MAP1LC3B Human trichostatin A multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 gene mutant form inhibits the reaction [trichostatin A promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]] more ... CTD PMID:29476062 MAP1LC3B Human trichostatin A increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 trichostatin A results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 MAP1LC3B Human trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of MAP1LC3B mRNA CTD PMID:28542535 MAP1LC3B Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of MAP1LC3B mRNA and trichostatin A results in increased expression of MAP1LC3B protein modified form CTD PMID:19606018 and PMID:20962572 MAP1LC3B Human trichostatin A increases cleavage EXP 6480464 trichostatin A results in increased cleavage of MAP1LC3B protein CTD PMID:20543569 MAP1LC3B Human triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of MAP1LC3B mRNA CTD PMID:34681664 MAP1LC3B Human trifloxystrobin increases expression EXP 6480464 trifloxystrobin results in increased expression of MAP1LC3B protein alternative form CTD PMID:27853101 MAP1LC3B Human trimethyltin decreases degradation ISO Map1lc3b (Rattus norvegicus) 6480464 trimethyltin results in decreased degradation of MAP1LC3B protein modified form CTD PMID:26459185 MAP1LC3B Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of MAP1LC3B mRNA CTD PMID:37042841 MAP1LC3B Human Triptolide increases expression EXP 6480464 triptolide results in increased expression of MAP1LC3B protein CTD PMID:31218727 MAP1LC3B Human trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of MAP1LC3B mRNA CTD PMID:33609687 MAP1LC3B Human trovafloxacin multiple interactions EXP 6480464 [trovafloxacin co-treated with TNF protein] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:33609687 MAP1LC3B Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of MAP1LC3B mRNA more ... CTD PMID:20962572 more ... MAP1LC3B Human tunicamycin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased expression of MAP1LC3B protein] CTD PMID:36640941 MAP1LC3B Human tunicamycin increases lipidation ISO Map1lc3b (Rattus norvegicus) 6480464 Tunicamycin results in increased lipidation of MAP1LC3B protein CTD PMID:37654027 MAP1LC3B Human tunicamycin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG5 protein mutant form inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:29793971 MAP1LC3B Human tunicamycin increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Tunicamycin results in increased lipidation of MAP1LC3B protein CTD PMID:29793971 MAP1LC3B Human tunicamycin increases prenylation EXP 6480464 Tunicamycin results in increased prenylation of MAP1LC3B protein CTD PMID:20593179 MAP1LC3B Human tyloxapol increases lipidation ISO Map1lc3b (Mus musculus) 6480464 tyloxapol results in increased lipidation of MAP1LC3B protein CTD PMID:36905866 MAP1LC3B Human tyloxapol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Escin inhibits the reaction [tyloxapol results in increased lipidation of MAP1LC3B protein] and Fenofibrate inhibits the reaction [tyloxapol results in increased lipidation of MAP1LC3B protein] CTD PMID:36905866 MAP1LC3B Human urethane increases expression EXP 6480464 Urethane results in increased expression of MAP1LC3B mRNA CTD PMID:28818685 MAP1LC3B Human valproic acid affects expression ISO Map1lc3b (Mus musculus) 6480464 Valproic Acid affects the expression of MAP1LC3B mRNA CTD PMID:17292431 and PMID:17963808 MAP1LC3B Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of MAP1LC3B mRNA CTD PMID:25979313 MAP1LC3B Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MAP1LC3B mRNA CTD PMID:22083351 more ... MAP1LC3B Human valproic acid increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Valproic Acid results in increased expression of MAP1LC3B mRNA CTD PMID:21318169 MAP1LC3B Human valproic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Valproic Acid results in increased expression of MAP1LC3B mRNA CTD PMID:20546886 and PMID:21427059 MAP1LC3B Human venlafaxine hydrochloride multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]] and Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein] CTD PMID:35104487 MAP1LC3B Human vinclozolin increases methylation ISO Map1lc3b (Rattus norvegicus) 6480464 vinclozolin results in increased methylation of MAP1LC3B gene CTD PMID:31682807 MAP1LC3B Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 MAP1LC3B Human vincristine increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Vincristine results in increased expression of MAP1LC3B protein CTD PMID:36808657 MAP1LC3B Human vincristine multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of MAP1LC3B protein] CTD PMID:36808657 MAP1LC3B Human vismodegib multiple interactions EXP 6480464 HhAntag691 inhibits the reaction [nickel monoxide results in decreased lipidation of and results in decreased cleavage of MAP1LC3B protein] CTD PMID:34608745 MAP1LC3B Human vorinostat affects localization EXP 6480464 vorinostat affects the localization of MAP1LC3B protein modified form CTD PMID:20543569 MAP1LC3B Human vorinostat multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 Chloroquine promotes the reaction [Vorinostat results in increased expression of MAP1LC3B protein modified form] CTD PMID:29476062 MAP1LC3B Human vorinostat increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Vorinostat results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 MAP1LC3B Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of MAP1LC3B mRNA and vorinostat results in increased expression of MAP1LC3B protein modified form CTD PMID:20962572 and PMID:22083351 MAP1LC3B Human vorinostat increases cleavage EXP 6480464 vorinostat results in increased cleavage of MAP1LC3B protein CTD PMID:17881280 and PMID:20543569 MAP1LC3B Human vorinostat multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [vorinostat results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:17881280 more ... MAP1LC3B Human wortmannin decreases expression ISO Map1lc3b (Mus musculus) 6480464 wortmannin results in decreased expression of MAP1LC3B protein CTD PMID:26847702 MAP1LC3B Human wortmannin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 wortmannin inhibits the reaction [Rotenone results in increased expression of MAP1LC3B protein] CTD PMID:26847702 MAP1LC3B Human zearalenone increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Zearalenone results in increased expression of MAP1LC3B protein CTD PMID:31586597 and PMID:32858132 MAP1LC3B Human zearalenone increases expression ISO Map1lc3b (Mus musculus) 6480464 Zearalenone results in increased expression of MAP1LC3B protein CTD PMID:34537261 MAP1LC3B Human zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAP1LC3B mRNA CTD PMID:18593933 MAP1LC3B Human zinc atom multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of MAP1LC3B protein] CTD PMID:32233808 MAP1LC3B Human zinc oxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 MAP1LC3B mutant form inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP3 protein] CTD PMID:24614525 MAP1LC3B Human zinc oxide affects lipidation EXP 6480464 Zinc Oxide affects the lipidation of MAP1LC3B protein CTD PMID:34766255 MAP1LC3B Human zinc oxide increases expression ISO Map1lc3b (Rattus norvegicus) 6480464 Zinc Oxide results in increased expression of MAP1LC3B mRNA and Zinc Oxide results in increased expression of MAP1LC3B protein CTD PMID:32951350 MAP1LC3B Human zinc oxide increases expression EXP 6480464 Zinc Oxide results in increased expression of MAP1LC3B protein CTD PMID:29289694 MAP1LC3B Human zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAP1LC3B mRNA CTD PMID:18593933 MAP1LC3B Human zinc(0) multiple interactions ISO Map1lc3b (Rattus norvegicus) 6480464 [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of MAP1LC3B protein] CTD PMID:32233808
